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ABSTRACT 
The effects of sample solvent composition and the 
injection volume, on the chromatographic peak profiles of two 
carbamate derivatives, methyl 2-benzimidazolecarbamate (MBC) 
and 3-butyl-2,4-dioxo[1,2-a]-s-triazinobenzimidazole (STB), 
were studied using reverse phase high performance liquid 
chromatograph. The study examined the effects of acetonitrile 
percentage in the sample solvent from 5 to 50%, effects of 
methanol percentage from 5 to 50%, effects of pH increase from 
4.42 to 9.10, and effect of increasing buffer concentration 
from ° to 0.12M. The effects were studied at constant and 
increasing injection mass and at four injection volumes of 
10, 50, 100 and 200 uL. The study demonstrated that the 
amount and the type of the organic solvents, the pH, and the 
buffer strength of the sample solution can have a pronounced 
effect on the peak heights, peak widths, and retention times 
of compounds analysed. MBC, which is capable of intramolecular 
hydrogen bonding and has no tendency to ionize, showed a 
predictable increase .in band broadening and a decrease in 
retention times at higher eluting strengths of the sample 
solvent. STB, which has a tendency to ionize or to strongly 
interact with the sample solvent, was influenced in various 
ways by the changes in ths sample solvent composition. 
The sample solvent effects became more pronounced as the 
iv 
injection volume increased and as the percentage of organic 
solvent in the sample solution became greater. The peak height 
increases for STB at increasing buffer concentrations 
became much more pronounced at higher analyte concentrations. 
It was shown that the widely accepted procedure of 
dissolving samples in the mobile phase does not yield the most 
efficient chromatograms. For that reason samples should be 
dissolved in the solutions with higher aqueous content than 
that of the mobile phase whenever possible. The results 
strongly recommend that all the samples and standards, 
regardless whether the standards are external or internal, 
be analysed at a constant sample composition and a constant 
injection volume. 
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I. Introduction 
In the last decade High Performance Liquid 
Chromatography (HPLC) has become one of the most widely used 
analytical techniques for a variety of purposes. This is due 
in part to the introduction .of sophisticated instrumentation 
but is primarily due to the methodology available to separate, 
identify and quantitate complex mixtures of compounds in a 
relatively short period of time. 
A. History of Chromatography 
In 1906 botanist Michael S. Tswett published the first 
paper (1) on chromatographic separation and coined the name 
"Chromatography". He described how components of a mixture 
(plant pigments) can be separated by elution through a packed 
column because of their different affinities for the column 
adsorbent. His work, however, was not widely recognized and 
chromatography held no significant importance until 1941 when 
Martin and Synge (2) published their historical paper on 
chromatography which led to the 1952 Nobel prize in Chemistry. 
The four major aspects of their paper were: 1) Theoretical 
treatment of separation process by expressing the efficiency 
of the column in terms of theoretical plate height; 2) 
Description of partition chromatography; 3) Recognition that a 
liquid moving phase can be replaced by a gas; 4) Recognition 
that the most efficient columns can be obtained by using very 
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small particles and by applying high pressure differences 
across the column. 
Chromatography has developed in stages since that time. 
Partition and paper chromatography were important developments 
in the 1940s, gas and thin-layer chromatography in the 1950s 
and gel or exclusion chromatography in the early 1960s. Modern 
High Performance Liquid Chromatography (HPLC) is only 18 years 
old. The first commercial equipment and column packings could 
be purchased in 1969. This was much later than for gas 
chromatography. The fast speed of development and improvements 
in this technique since then is due to several factors: 1) 
Thorough understanding of Gas Chromatographic (GC) theory; 2) 
Operational advantages over traditional column chromatography, 
thin layer and paper chromatography in terms of speed, 
accuracy, convenience and the ability to separate complex 
mixtures (3-5). 3) Wide range of applicability. While gas 
chromatography is limited to separating only 20 percent of 
known organic compounds without further derivatization (6) 
(since the rest are either insufficiently volatile or 
thermally unstable), HPLC can separate any compound that is 
soluble in a liquid suitable for use as a mobile phase. It has 
found a wide range of applications in the biomedical (7), 
natural product (8), enviromental (9,10) and polymer (11) 
fields. It is used in analysis and separation of proteins, 
nucleic acids, amino acids, polysaccharides, plant pigments, 
lipids, pharmaceutical products, drugs, pesticides, steroids, 
vitamins, flavor enhancers, enviromental pollutants and 
3 
polymers. 
B. HPLC Instrumentation 
The basic principles of HPLC and classical column 
chromatography are similar~ In both, physical separation of 
different molecular species occurs on the packed column using 
liquid as a mobile phase. HPLC, however, employs much more 
sophisticated equipment, which allows separation at high 
pressure (usually up to 40 megapascals) and constant and 
reproducible flow (usually from 0.01 to 10 mL/min) using long 
life, reusable columns. These factors are responsible for 
major HPLC advantages of convenience, accuracy, speed of 
analysis and the ability to carry out com1plex separations. 
The basic HPLC set-up is illustrated in Figure 1. The main 
components" are: 
(1) Degassed solvent reservoir. Degassing is usually required 
to avoid pressure fluctuations. 
(2) Pump system. It is capable of delivering pulseless and 
reproducible mobile phase flow usually in the range from 0.01 
to 10 mL/min. It 1Ilust be compatibl-e wit"h'orga-ni-c -a-n1i-a-queous 
solvent systems. The two piston reciprocating pumps with pulse 
dampeners are most popular at present. Other types include 
syringe-type pumps, pneumatic pumps and hydraulic amplifier 
pumps. 
(3) High-pressure injector. There are four basic types: 
high-pressure septum injector,high-pressure stop-flow 
q-
10 r-~-2l-1-rC:- 4 I 
----. ,.---
5 [J-8 
~J O-{J 
figure 1; Block Diagram of Liquid Chromatograph: 1) Mobile Phase Reservoir; 2) Pump; 3) High 
Pressure Injector; 4) Thermostated Stainless Steel Column; 5) Detector; 6) Detector 
Electronics; 7) Recorder; 8) Sample Collection; 9) Flow Measurement; 10) Programmer. 
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injector, loop injector and syringe-loop injector. The 
syringe-loop type seems to be the most widely used. 
(4) Column. The most commonly used column is a closed, usually 
stainless steel, column from 5 to 30 cm in length and 1 to 4.6 
mm in internal diameter, capable of withstanding pressures up 
to 40 megapascals. It is packed with uniform small size 
particles (3-10 pm) and is connected with narrow bore tubing 
to the injector and detector to minimize dead volume which 
causes band broadening. 
(5) Detector. It is used to identify and quantitate separated 
components. Three major requirements are high sensitivity 
(10- 6 _10- 9 g/mL range), high signal to noise ratio, and large 
linear response range. Most widely used are refractive index, 
UV absorption, fluorometric and conductivity detectors. With 
the introduction of microbore columns (12), infra red (13), 
electrochemical (14) and mass spectrometTic detectors (15,) 
are gaining in importance. 
C. Theory of Chromatographic Separation 
Chromatographic separations can~be obtained when there 
-.~ 
is a difference in specific affinities of solute components 
for the stationary phase and moving phase. Figure 2 
illustrates several steps in the separation process. In step 
1, the sample is introduced through an injection port into the 
continuously flowing mobile phase stream. A tight band of 
solute molecules is formed at the head of the column. In step 
6 
FiQure 2: Steps in Chromatographic Separation: 1) Sample Intorduction; 2) Chromatographic 
Separation; 3) Sample Detection. 
~~~II------~~I I~~----~ 1 
2 
3 
Figure 3: MajorECirameters ofaChrornatogram:' To·a:·deadtime, Vo= dead volume,T.r1==retention time 
tor component 1, V r1 = retention volume tor component 1, T r2= retention time tor 
Vo 
component 2, h1 = peak height tor component 1, w1 = peak width tor component 1, w112 = 
peak width at half height. 
I/r/ 
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2, sample is carried down the column and due to the different 
interaction of each component with the stationary and moving 
phases, each component travels at a different speed down the 
column. There is also some band broadening present, due to 
undesirable diffusion processes occurring in the column during 
the separation. Since the ~njection solvent is not retained by 
the stationary phase, it travels down the column at the same 
rate as the mobile phase flow and always elutes first at 
retention time To. In step 3, the separated components elute 
from the column and enter the detector, which sends a response 
to a constant speed strip-chart recorder, or to a computer 
terminal. Results are plotted in the form of detector response 
versus the time taken for each component to be eluted 
(retention time) Tr(i). This type of plot is known as a 
chromatogram. 
Figtire 3 illustrates a typical .chromatogram with the 
parameters used to characterize it. Each component elutes 
independently of others from the column and can be described 
by the set of independent variables: dead volume Vo or dead 
time To, retention volume Vr(i) or retention time Tr(i), peak 
width Wei), and peak height h. From the above parameters the 
capacity factor k'(i) can be calculated using equation [1]: 
k'(i) = [Vr(i)-Vo]!Vo eq. [1] 
or if the eluent flow rate is constant, the retention times 
can be used in place of Vr as shown in equation [2]: 
k'(i) = [Tr(i)-To]!To eq. [2] 
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Capacity factor k'(i) is one of the most important factors in 
chromatography. It relates equilibrium distribution of the 
sample to the thermodynamic properties of the column and can 
also be described by equation [3]: 
k'(i) = Cs(i)Vs!Cm(i)Vm eq. [3] 
where Cs(i) = concentration of the solute in the stationary 
phase, Cm(i) = concentration of the solute in the mobile 
phase, Vs = volume of the stationary phase in the column, Vm = 
volume of the mobile phase in the column. The ratio 
Cs(i)!Cm(i) = Kd, is known as a distribution coefficient. Kd 
is constant for a specific system if the temperature is kept 
constant and the distribution isotherm is linear, giving 
symmetrical elution peaks. When the distribution isotherm 
deviates from linearity, elution profiles become asymmetric 
with peak tailing or leading edges appearing (16). Peak 
tailing indicates adsorptive effects and retention time for 
the components decreases with increasing sample size. A 
leading edge indicates a concave isotherm. Here~ increasing 
sample size increases component retention time, and 
symmetrical peaks can be achieved by decreasing the sample 
load (16). Since the above values are difficult to obtain 
during chromatographic analysis, equations [1] and £21 are 
used most of the time to calculate k'. Another important 
separation factor is resolution Rs between the two adjacent 
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bands. It is determined by the performance of chromatographic 
system which is influenced by the choice of mobile and 
stationary phases, temperature, and length of the column. 
Resolution of 1.5 or higher indicates complete separation. It 
can be readily calculated from equation [4]: 
eq. [4J 
Chromatographic separation can also be considered as a 
series of extractions, as mobile phase moves past the 
stationary phase. The single equilibrium extraction occurs 
over a specific length of the column and is known as a 
theoretical plate. The number of theoretical plateB (N), which 
exhibits the efficiency of the column, characterizes the 
entire chromatographic separation system, and is a convenient 
measure to assess the band spreading. N is determined from 
equation [5J: 
N = 5.52 [Tr(i)/W(i)at h1/2]2 = 16[Tr(i)/W(i)]2 eq. [5] 
Efficiency can also be expressed as the height equivalent to a 
theoretical plate (HETP) from equation [6]: 
H = L/N eq. [6J 
Smaller H means better column efficiency and smaller band 
spreading. By comparing the theoretical plate heights of two 
columns, one can get direct measure of relative column 
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efficiency. The factors that affect the degree of ba~d 
spreading are given by the Van Deemter equation [7] (17) 
HETP=l/[(l/C d )+(l/C d 2u/D )]+CdD /u+C d 2u/D eq. [7] 
e p m p m m sm p m 
where d is the diameter of column packing particles, u is the p 
mobile phase velocity inside the column, D and Dare 
m 5 
molecular diffusion coefficients of the sample in the moving 
and stationary phases respectively, and C , C ,C ,C, Cd 
e m sm s 
are constants characteristic of the packing. Equation [7] 
states that smaller HETP and improved separations are favoured 
as particle size and mobile phase velocity decrease, as mobile 
phase solvents become less viscous, as separation temperature 
increases and as size of sample molecules decreases. 
Under fixed chromatographic conditions (same solid 
phase, mobile phase, flow rate, temperature and detector), the 
retention times of components remain constant. This property 
is the key to the success of the chromatographic method. It is 
used in qualitative analysis to identify the presence of 
specific components in the sample by comparing the retention 
times of unknown components to the known standards. The bulk 
of chromatographic analysis, however, is quantitative. Here 
peak height and peak area are used to quantitate analytes 
because they are proportional to the component concentrations. 
The concentrations of the components analysed must be within 
linear range of the detector so that the peak height or peak 
areas of unknown samples can easily be compared to those of 
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the standard concentrations. Results obtained using peak areas 
are less affected by the reproducibility of the peak shapes 
between samples and standards, since the peak area is a 
function of the peak height and one half peak width for 
symmetrical peaks. In many instances (18,19) it is impractical 
to use peak areas, due to unresolved baselines, and peak 
height is the method of choice. This is especially true when 
samples have to be extracted from plant or living tissues 
where coextractants interfere (20). In these cases, it is 
essential that the peak shape remains constant throughout the 
analysis of both samples and standards. If the peak broadening 
occurs and peak height decreases, a significant error in the 
results can be expected. 
D. Methods in HPLC 
1. Liquid-Solid or Adsorption Chromatography (LAC) 
Adsorption chromatography is the oldest of the four 
methods. It involves a polar solid stationary phase such as 
silica or alumina and a non polar or less polar liquid mobile 
phase, such as pentane or hexane using smaller amounts of a 
more polar organic modifier, such as dichloromethane or 
methanol to regulate adsorption properties. Separation occurs 
when polar solute molecules are adsorbed on to the surface of 
the stationary phase and are eluted in increasing order of 
polarity (21). LAC is suitable for samples that are 
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organic-soluble with intermediate molecular weight of 150-1500 
(16) and are nonionic. It is the best method for separating 
isomeric mixtures. 
2. Ion-Exchange Chromatography 
Ion-exchange ~hromatography (IEC) was first used for 
separation of rare earth, and various fission products in the 
development of atomic energy. Today it is used in the analysis 
of protein structures (22), agricultural chemicals (23), drugs 
(24), trace analysis of compounds in soil and surface water 
(25), food and food additives (26) and many other substances. 
IEC involves the use of a stationary phase which has positive 
or negative charge-bearing functional groups and mobile phase 
containing the counter ion. The sample ions are in competition 
with mobile phase ions for the stationary exchange sites. The 
separations are based on the different strengths of 
interaction of analytes between the sample ion and the 
exchange sites. 
3. Size Exclusion Chromatography 
Size Exclusion Chromatography (SEC), also known as Gel 
Permeation Chromatography (GPC) is the newest of the four 
chromatographic methods. It was first introduced by J. C. 
Moore (27) of Dow Chemical Company in the early 1960s. It is a 
relatively simple, yet rapid method that can separate high 
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molecular weight polymers or just simple low molecular weight 
mixtures. The separation occurs strictly on the basis of 
molecular size. One of the major differences from other 
methods is the relative unimportance of solvent type. Here the 
pore size of the packing has the largest effect on separation 
characteristics. A change in column packing is comparable to a 
change in the composition of the mobile phase in other 
methods. Packings are usually highly porous gels of uniform 
pore size such as sulfonated polystyrene/divinylbenzene resin, 
polyvinyl alcohol gels, polyester gels, cross-linked 
dimethylbenzene-polystyrene gels, and porous silica 
microspheres which have shown highest performance up to date. 
4. Partition Chromatography on Bonded Stationary Phases 
Partition Chromatography, often quoted as liquid-liquid 
chromatography, involves a separation of analytes between two 
immiscible liquids. One liquid is a mobile phase and another 
liquid which is usually covalently bonded on to the silica gel 
surface by siloxane bridges as a stationary phase. The process 
is similar to the solvent partition between two immiscible 
liquids in a separatory funnel, except that this method is 
much faster and more efficient. By selecting an appropriate 
pair of partitioning liquids almost infinite separation 
capability can be achieved. 
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1) Normal-Phase Chromatography 
A chromatographic system known as Normal-Phase 
Chromatography uses the combination of polar bonded stationary 
phase and less polar mobile phase. The functional groups in 
the most frequently used bonded stationary phases are: Cyano, 
Amino, Diamino, Dimethylamino and Glycol phases. The mobile 
phase usually consists of a non polar organic solvent such as 
hexane with a polar modifier such as isopropanol. Since 
reproducibility of retention values and peak symmetry is 
significantly better for polar bonded phases than for regular 
silica gel packing, these phases are slowly replacing 
classical polar adsorbents such as silica and alumina. 
2) Reversed-Phase Chromatography 
Howard and Martin (28) first reported the use of a nonpolar 
liquid stationary phase (paraffin and octane) with a polar 
mobile phase (methanol-water or methanol-acetone mixtures) in 
1950. Since phase polarities were in reverse to the 
conventibnal system, this chromatographic method has become 
known as Reversed-Phase Chromatography (RPC). There was little 
development in this field however, until Stewart and Perry 
(29) introduced a true bonded nonpolar phases in 1968. In the 
past several years, the microparticulate nonpolar bonded 
phases enjoyed the greatest popularity. Today Reversed-Phase 
High Performance Liquid Chromatography (RP-HPLC) is the most 
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widely used analytical technique. It is estimated that around 
80% of all analytical separations are carried out using this 
technique. 
The versatility of this technique is largely due to the broad 
range of mobile phase compositions. These can range from 
completely aqueous through any number of aqueous-organic 
mixtures to completely nonaqueous. Since this branch of 
chromatography is used in the present study, the factors 
influencing separation in RP-HPLC will be examined in more 
detail in the following. 
E. Factors Affecting Efficiency of Separation in RP-HPLC 
1. Stationary Phase 
The stationary phase in RP-HPLC is usually a nonpolar 
covalently bound hydrocarbonateous octyl, phenyl or octadecyl 
silica, octadecyl silica being most popular. In section IC it 
was shown that column separation efficiency increases with a 
decrease in the particle size of the column packing. At 
present the most common silica gel particles are in the range 
of 3-10 ~m in diameter and uniform in size. After the proper 
size of silica gel is selected, it is washed with aqueous acid 
to generate a high concentration of reactive silanol (SiOH) 
groups at the surface. The treated silica is then reacted with 
a silanizing agent as shown in Figure 4. If 
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FIG U R E 4 *: Preparation of Hydrocarbonaceous Bonded Phases. 
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Table 1* 
Some Commercially Available Rp··HPLC Stationary Phases 
Name Functionality Base Material Particle Size Description 
(Jun) 
Partlsil ODS-2 Octadecylsilane Partisil 10 16% Loading 
LiChrosorb RP-18 Octadecylsilane LiChrosorb 5,10 Monolayer, Stable pH 1-9, 
22% Loading I-' ...... 
Spherisorb ODS Octadecylsilane Spherisorb 5,10 Spherical, Maximum pH 8, 
8% Loading 
Zorbax ODS Octadecylsilane Zorbax 6-8 15% Loading 
LiChrosorb RP-8 Octylsilane LiChrosorb 5,10 Monolayer, Stable pH 1-9, 
13-14% Loading 
"from Reference 16 
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alkyldimethylchlorosilane is used in silanization, a nonpolar 
covalently bound "brush" is formed on the surface (30). If the 
silanizing agent has three reactive groups such as 
trichlorosilane, the product is a nonpolar crosslinked 
alkylpolysiloxane or bulk modified layer (31) which enhances 
coverage of surface silanol.groups as shown in Fiure 4. It is 
impossible to derivatize all the silanol groups due primarily 
to the steric hindrance from large R groups. It has been shown 
that more than half of all initially present surface silanols 
remain underivatized (32). 
The percentage of free silanol groups determines the 
chromatographic properties of the particular stationary phase. 
It has been shown (33) that these residual silanol groups 
exhibit strong influence on the chromatographic behavior of 
polar and hydrogen bonded solutes. A reduction in the number 
of surface silanols is possible by reaction with 
trimethylchlorosilane. This process is known as endcapping and 
was shown to enhance stability of the stationary phase (34). 
Bij et ale (35) reported that uncapped stationary phases 
exhibit higher selectivity in some separations. Table I lists 
some properties of alkyl-silica bonded phases. 
There are a large number of commercially available 
nonpolar bonded phases. Each having somewhat different 
retention properties which depend on a) Surface area and pore 
size distribution of the silica; b) Chemical nature of the 
bonded hydrocarbonaceous moiety; c) Carbon loading on the 
stationary phase; and d) Surface concentration of accessible 
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silanol groups. Silica based, nonpolar bonded stationary 
phases give optimum performance in the pH range from 2-8. In 
basic eluents, hydrolysis of the silica matrix occurs, which 
can result in the loss of some organic ligands. In recent 
years, packings from C18-derivatized 
polystyrene-divinylbenzene ~olymer have been introduced. These 
packings claim high stability and very good reproducibility in 
the pH range from 0-14 (36). 
There is still a lack of complete understanding of the 
mechanism of solute retention in reverse phase liquid 
chromatography (37,38). The main reason for this is incomplete 
understanding of the physical nature of bonded stationary 
phases and their interaction with the mobile phase and solute 
molecules. A significant number of papers have been published 
elucidating retention mechanisms on nonpolar bonded phases. 
Present understanding is that there are actually three 
retention mechanisms (39), the primary mechanism being the 
partition between two liquids, the stationary and mobile 
phase. The second mechanism suggested by Horvath and Melander 
(40,41) involves an adsorption mechanism where solute 
molecules are adsorbed onto the nonpolar stationary phase by 
Van der Waals dispersion forces. The more polar solutes have a 
stronger interaction with the polar mobile phase and elute 
faster. Scott and Kucera (42) proposed that the organic 
modifier in the mobile phase is preferentially adsorbed onto 
the bonded phase forming a monolayer with which the solute 
molecules interact. In this case, the stationary phase serves 
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only as a support. Scott and Simpson (43) have further shown 
that the desorption-adsorption coefficients decrease and the 
distribution coefficients between water and the reverse phase 
increase exponentially with the carbon number of the 
moderator. This suggests that the surface of the reverse phase 
is significantly altered in the presence of the organic 
modifier. They also found that the dispersive interactions 
between the reverse phase and the solute hydrocarbon chain are 
independent of the solute functional groups. 
Scott and Simpson (44) studied retention characteristics 
of "brush" and "bulk"-type reversed phase column packings. 
They found that the "brush" type reverse phase packings can 
undergo internal association at low organic modifier 
concentrations and minimize the effective surface area, 
resulting in lower retention times than expected. These type 
of phases need a significant amount of time to equilibrate at 
low modifier concentrations. The "bulk"-type bonded phases do 
not exhibit dispersive interactions, equilibrate much faster 
and exhibit the expected retention behavior. 
Tanaka et al.(45) found that the planar solutes were 
preferentially retained by the planar stationary groups such 
as octadecyl or large aromatic rings, while aromatic 
stationary phases showed preferential retention for aromatic 
and polar solutes. 
Stahalberg and Almgren (37) studied the effects of 
mobile phase composition on the polarity of reverse phases. 
They found that with increasing concentration of methanol in 
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the solvent there was a decrease in the polarity of the RP-2 
and RP-18 surfaces. This decrease in the polarity of the 
reverse stationary phase was explained by preferential 
adsorption of methanol molecules to the free silanol groups 
through hydrogen bonding. In this way nonpolar methyl groups 
are exposed to the solute and mobile phase interactions. They 
also observed that acetonitrile-water mixtures do not behave 
in the same manner, but that the surface in contact with 
acetonitrile-water mixtures shows an increase in polarity. 
This was explained by two processes: the adsorption of 
acetonitrile through hydrogen bonding which results in a 
decrease in polarity, as in the case of methanol; in addition, 
freely moving acetonitrile molecules enter between alkyl 
chains resulting in an increase in the polarity of the surface 
layer. 
2. Temperature 
Most separations at present are carried out at constant, 
most often room temperature. With the introduction of 
microbore columns (46) there is more interest in temperature 
programming which would increase efficiency and decrease 
retention time. 
Melander and coworkers (47) found that retention 
decreases and efficiency increases with an increase in 
temperature. This can be explained by the reduction in mobile 
phase viscosity and faster equilibration between the 
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stationary phase and mobile phase. Melander et al.(59) also 
found that in buffered solutions where the pH is close to the 
pKa of the buffer and the eluate, Vanlt Hoff plots of the 
retention factors can deviate from linearity and in some cases 
can increase with temperature. 
3. Mobile Phase 
As mentioned earlier the ability to control selectivity 
by choosing from an infinite number of mobile phase 
compositions makes RP-HPLC such an attractive analytical 
technique. Here one changes the mobile phase composition as 
one changes the column packing in GC analysis to achieve the 
desired separation. The desired properties of the eluent are 
low viscosity, high optical transparency at low wavelengths 
and the appropriate eluotropic strength. In the reverse phase 
chromatography, the most polar solvent (water) is the weakest 
eluent, and eluent strength increases as polarity of the 
solvent decreases. Table II lists properties of some solvents 
used in chromatography. Acetonitrile, methanol and 
tetrahydrofuran are most popular organic solvents due to their 
low viscosity and high UV transparency (48). Four solvent 
characteristics that contribute the most to the selectivity of 
the eluate-eluant system are: solvent polarity or 
chromatographic strength, proton acceptor and proton donor 
character, and strong dipole character (49). 
For most analyses, eluents stronger than water and 
Acetonitrile 
Ethanol 
Methanol 
T etrahydrofu ran 
Water 
a Density at 20°C 
b Viscosity at 20°C 
c Dielectric Constant 
d Dipole Moment 
e Surface Tension 
m.w. 
41.0 
46.1 
32.0 
72.1 
18.0 . 
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Table 11* 
Properties of Common Organic Solvents 
Used as Modifiers in RP-HPLC 
B.P.(oG) pa(gcm-3) llb(cP) £C 
82 0.782 0.358 38.80 
78 0.789 1.190 24.50 
65 0.792 0.584 32.70 
66 0.889 0.510 7.58 
100 0.998 1.000 78.50 
*Values obtained from Reference 30(p.166) 
J.! d(Debye) "f(dyncm-1) 
3.37 29.0 
1.68 22.0 
1.66 22.0 
1.70 27.6 
1.84 73.0 
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weaker than pure organic solvent are desired. This is obtained 
by mixing various amounts of water with the organic solvent. 
Another way of achieving desired eluent strength, and at the 
same time reduce retention is by the use of gradient elution. 
This is achieved by the use of two solvent reservoirs and by 
increasing the percentage of organic modifier as the analysis 
progresses. Schoenmakers et al.(50) studied the relationship 
between retention volume and solvent composition in a linear 
gradient. Ternary and quaternary mixtures have found some use, 
due to highly stable pumping systems (51), but still the most 
popular solvent delivery system is isocratic, and most studies 
concerning eluent influence are carried out under isocratic 
conditions. 
The effects of mobile phase composition on the 
selectivity, retention properties and peak shape have been 
studied extensively (50,52,53,54). Schoenmakers et al.(50) 
found quadratic relationship between the logarithm of the 
capacity factor and the volume fraction of organic midifier 
eq.[8] for mobile phases containing less than 90% water. Their 
study involved full range of compositions for methanol, 
acetonitrile and tetrahydrofuran. 
In Ki = AQ2+ BQ + C eq.[8] 
Q = organic modifier fraction 
Karger et al.(54) found that the methylene group selectivity 
is a linear function of the solvent composition. For 
methanol-water mixtures selectivity decreases with a decrease 
in water content of the mobile phase. For acetonitrile-water 
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Table 111* 
The Apparent pK* Values of H2P04- and HP04= 
for Methanol-Water Mixtures 
[MethanoG ok* H PO -
.24 pK* HP04= 
%vlv 
0.00 2.2 6.9 
19.01 2.3 7.1 
38.02 2.4 7.3 
57.03 2.8 7.9 
76.04 3.6 8.8 
88.72 4.9 9.6 
*data taken from ref.(S7) 
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mixtures, a linear trend is observed up to ca. 40 percent of 
the acetonitrile composition. Tanaka et al.(55) found that 
different organic modifiers exhibit significantly different 
selectivities for aromatic solutes and that the increasing 
order of selectivity for different organic modifiers 
corresponds to the order of decreasing eluent strength. 
Another very popular method of modifying the aqueous 
component of the mobile phase is through the use of buffering 
agents. Buffers are essential for controlling selectivity in 
ionizable eluates which include most biological molecules. The 
degree of ionization of weak electrolytes is strongly affected 
by the mobile phase pH in the area of their pKa. The plot of 
retention factor k' v. pH of the mobile phase is a sigmoidal 
curve with the midpoint pH value corresponding to the pKa of 
the acid (56). Ionization of the eluent usually results in 
shorter retention times. Buffers can also interact with 
surface silanols and in this way affect retention or peak 
shape of nonionizable substances, or they can interact with 
solute molecules themselves. 
The ideal buffer should have uniform buffering capacity 
in the pH range 2-8, be optically transparent down to 200 nm, 
be soluble in organic solvents,have potential for masking 
silanol groups of the stationary phase, and be able to 
accelerate the rates of protonic equilibria. The 
alkali-phosphate buffers have most of the desired properties 
and are extensively used in RP-HPLC. Leitold and Vigh (57) 
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= reported pK of HP0 4 and HZP0 4 in various methanol-water 
mixtures. They found that as percentage of methanol increases 
the pK of both salts increases as illustrated in Table III. 
Ishimitsu and Hirose (58) studied the effects of pH on 
the retention behavior of catecol amino-acids using phosphate 
buffers in the mobile phase~ They found that the capacity 
factor k' depends on the type of solute functional group, and 
on their pKa as well as on the pH of the eluent. The compounds 
with pKa higher than 6.0 were independent of the pH of the 
eluent up to pH of 5.5 and eluted in order of decreasing 
polari~y as expected for true partition chromatography. The ~ 
-hydroxy carboxylic acid derivatives exhibit shorter retention 
as the pH increases from Z.6-5.5 due to increased ionization. 
A marked increase in retention for some compounds was observed 
when the pH of the mobile phase was raised from 4.5-8.5. This 
was attributed to the increase in availability of phosphate 
anionic species that can form ion-pairs with these compounds. 
As quoted before Melander et ala (59) found that in 
buffered solutions Van't Hoff plots of the retention factors 
can deviate from linearity, and in some cases retention can 
increase with temperature. They attributed this to complex 
formation between sample molecules and buffer species and to 
masking of the silanol groups of the stationary phase with 
buffer molecules. 
Pepp and Vigh (60) investigated retention behavior of 
low, medium and high pK aromatic amines using LiChrosorb RP-18 
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column and acidic aqueous methanol eluents. The eluents, at 
constant pH, also contained varying concentrations of sodium, 
potassium and tetra-methyl ammonium salts. They found that 
salt addition decreased the retention time of protonated 
amines and to a smaller extent that of the polar, non-ionic 
solutes. They attributed this trend to the ion exchange of the 
protonated amine with the dissociated silanols of the RP-18 
stationary phase. 
It is an accepted fact that the main use of buffers is to 
maintain the pH of the solution constant, and to serve as 
background eloctrolytes, but in RP-HPLC proper selection of 
buffers is essential since buffers can not only enhance 
resolution but can also cause poor efficiency and assymetric 
peaks. 
4. Sample Solvent 
The effects of sample solvent composition in RP-HPLC are 
still poorly understood. It has been shown by several groups 
(61-67) that the chromatographic efficiency in RP-HPLC is 
sensitive to the injection conditions. Two major factors are 
volume of the injection and the composition of the sample 
solvent. 
Lawerence (61) snggested that the sample solution should 
contain a slightly larger percentage of water than the mobile 
phase. This slight excess of water will cause solute molecules 
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to collect at the head of the column in a narrow band, while 
sample solution passes onto the column. He observed that the 
injection of solutes in 100% methanol, acetonitrile or other 
organic solvents can significantly reduce chromatographic 
efficiency if mobile phase has large percentage of water. The 
reason for this is that organic solvents tend to wash the 
solute down the column at the faster rate than does more polar 
mobile phase. 
Snyder and Kirkland (62) reported that the sample size 
should be less than the linear capacity of the column. As the 
sample size reaches the critical size a noticeable decrease in 
retention time and resolution is observed. Tsimidou and Macrae 
(63) observed a significant decrease in resolution as 
injection volume increased. For packed columns, injection 
volumes used could vary from 5 to 100 ~L (64). 
F. Scope of My Research 
As reported previously, there are well documented 
studies on the influence of mobile phase composition on the 
resulting chromatogram. In RP-HPLC the organic modifier 
composition significantly influences retention time of eluite 
and changes in the pH of the eluant can often modify the 
retention of some substances dramatically. It was also shown 
(60) that the ionic strength influences retention. 
Very little has been written about influences of the 
injection solvent composition on the resulting chromatogram. 
30 
FI G U R E 5: Structures of compounds studied 
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Most texts advise the use of a solvent composition as in the 
mobile phase, but this is very often impractical or impossible 
due to different extraction procedures, different solubilities 
of the components being analysed, or just inconvenience of 
dilution. As the columns become smaller, the injection volume 
will become more important since detector sensitivity will 
limit further reduction in the injection volume and 
overloading factors will become more important. 
Chiba and Singh (65) in their study of fungicide Benomyl 
(I), and its degradation products methyl 
2-benzimidazolecarbamate (MBC) (II) and 
3-butyl-2,4-dioxo[1,2-a]-s-triazinobenzimidazole (STB) (III), 
observed that the composition of the injection solvent can 
significantly affect the retention time and the peak shape of 
the resulting chromatograms. Since the major objective of 
their studies was not to investigate the systematic effects of 
injection solvent, it was decided that a separate study should 
be carried out on the influence of injection solvents in 
RP-HPLC of these compounds. It was especially interesting 
since very few published papers (66,67) could be found dealing 
with this topic. It was felt that this lack of published 
papers indicated a lack of understanding of the importance of 
this topic. This disregard for the injection sample 
composition can be seen currently in the literature where 
sample solvent composition is almost never mentioned, and even 
injection volume is excluded in many instances. It was felt 
that understanding the effects of injection solvent 
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composition on the peak profiles is very important in 
quantitative work. This is especially true if an internal 
standard is used which could be affected to a different degree 
than the compound of interest. 
Tseng and Rogers (66) reported that dihydroxybenzene 
isomers dissolved in methanol and eluted with water result in 
broad peaks, shoulders or even split peaks. They attributed 
these effects to the incomplete mixing of the mobile phase and 
the injection solvent. 
williams et al.(67) observed that the substantial 
improvements in the chromatographic performance may be 
achieved by optimization of the injection solvent composition. 
They observed significant decreases in the peak height when 
acetonitrile content in the injection solvent exceeded that of 
the mobile phase. The same solutes in methanol-water mixtures 
showed a peak maximum around 30 % methanol. It was also 
observed by this group that solutes with a high capacity 
factor exhibit a lesser degree of peak broadening. Both of 
these groups had no theoretical explanation for these 
occurences. It was hoped that from our study we could 
elucidate a mechanism to account for these effects. 
My study started in 1982 but due to the circumstances of 
being a part-time study, it took several years to complete. 
During this time Tsimidou et ale published two papers (63,68) 
on the influences of injection solvent composition in the 
reversed-phase chromatograpy of triglycerides. They examined 
effects of injection solvent type, polarity of the binary 
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mixtures and the injection volume on the peak shape of 
trilaurin and olive oil. 
Ng and Ng (69) reported the effects of injection solvent 
composition on the peak shape of caffeine and salicylamide. By 
using computer simulated chromatography to reproduce peak 
distortions, they suggested .two main reasons for these 
distortions. One is a difference in retention ratios between 
the injected solvent and the mobile phase, and the other is a 
change in the retention capacity of the column due to the 
adsorption of the injection solvent onto the column. 
Perlman and Kirschbaum (70) studied the effects of 
ethanol, methanol and water compositions in the injection 
solvent on a series of compounds. They observed that only 
compounds capable of forming intramolecular hydrogen bonding 
exhibited decrease in peak heights with an increase in organic 
solvent. 
Nilsson and Westerland (71) found that the type and the 
concentration of organic anions present in the injection 
solvent can have significant influence on the chromatographic 
efficiency of several benzamides. They observed that as the 
concentration 6f organic anion increased peak sharpening 
occured for some benzamides, while for others it had no 
effect. They explained this by formation of depletion zones 
due to replacement of organic modifier on the surface of 
stationary phase with the organic anion from the injection 
solvent. 
Kirschbaum and Perlman (72) observed split peaks when 
hydrochlorothiazide was dissolved in methanol and 50 pL of the 
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solution was injected. When the same compound was dissolved in 
the mobile phase solvent and 200 nL of the solution was 
injected, a normal singlet peak was obtained. The mobile phase 
used in this case was water-methanol-phosphoric acid 
(75:25:0.02). The reason for splitting is injection of sample 
in the solvent stronger than mobile phase. This group also 
observed that peak height for captopril injected in 
methanol-water mixtures increased with an increase in water 
content. Their explanation for this is formation of 
intermolecular and intramolecular hydrogen bonding in methanol 
which could not exist in aqueous solutions. 
Several groups (73-76) have reported presence of 
anomalous peaks. They were expressed differently as ghost 
peaks (74), vacant peaks (75) or system peaks (76). In each of 
the above cases the injection solvent was significantly 
different from the mobile phase composition. 
Rouchouse et ale (77) studied the effects of the sample 
solvent and the injection volume on the efficiency of columns 
with 3-~m packings. They found that the efficency is a 
function of the sample solvent composition and the injection 
volume. 
However, none of the authors discussed the sample 
solvents which were buffered. 
In this study, the effects of six factors in the sample 
solvent composition were studied on the retention time, peak 
heigth, peak width, peak area and peak symmetry. The effects 
studied were: 
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1. Effect of acetonitrile percentage in the range of 5-50 "7 •• 
2 • Effect of methanol percentage in the range of 5-50 "7 •• 
3. Effect of pH in the range of pH 5-8. 
4 . Effect of buffer concentrations in the range of 0-0.12 M. 
5. Effect of injection volume at constant mass from 10 to 200 
J.lL. 
6. Effect of injection volume at increasing mass from 10 to 
200 .ilL. 
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II. Experimental 
A. Instruments 
Two HPLC systems were used for chromatographic analyses. 
One was a Perkin-Elmer (PE). Series 3 High Performance Liquid 
Chromatograph which was equipped with a Rheodyne constant 
volume sample-loop injector and a Perkin-Elmer LC-55-S UV 
detector. Another one was a Hewlett-Packard HP-l090 LC System 
which was equipped with a HP-79835A solvent delivery system 
with the flow stabili~y of better than 1%, a HP-i9846A 
autoinjection module which has a programmable injection 
capability in the volume range from 1 to 250 pL using a 
syringe-loop injector and an HP-1040A diode array 
spectrophotometric detector. The latter was also equipped with 
an HP-85B personal computer. The HP-l040A diode array 
spectometric detector is capable of generating chromatographic 
signal (absorbance vs time) used in quantitation of a 
compound, and a spectrum of a compound (absorbance vs 
wavelength) which provides qualitative structural information. 
A Regis Hi-Chrom reversible column, 5-pm Sperisorb ODS 
(C-18) 15 cm x 4.6 mm (i.d.) was used throughout the study. A 
precolumn [5 cm x 4.6mm (i.d.)], dry packed with CO PELL ODS 
37-40 pm (Whatman), was used along with the analytical 
column. 
An Accumet(R) pH meter model 810 from Allied Fisher 
Scientific equipped with a Fisher combination electrode, and a 
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Metrohm 632 pH meter from Brinkmann Sci., equipped with a wide 
range Mtrohm combination electrode, were used for pH 
measurements. Electrodes were standardized with pH 6.96 and pH 
4.01 buffers. The pH precision was +/- 0.02 pH units. 
For measurements of UV absorbance of the sample 
solutions before HPLC analY$is, a Varian DMS 100 UV-Visible 
Spectrophotometer was used. Time constant was 0.3 sec., slit 
width was 1.0, absorbance full sacale was 0-1.0 AU, and 
scanning range was 340 to 240 nm. This instrument is capable 
of wavelength accuracy of better than 0.4 nm and wavelength 
reproducibility of better than 0.2 nm. 
Nuclear Magnetic Resonance (NMR) spectra were recorded 
on Bruker AC 200 NMR. Electron impact (EI) and fast atom 
bombardment (FAB) mass spectra were obtained on a Kratos (AEI) 
MS-30 double beam, double focusing mass spectrometer, 
retrofitted with a Kratos FAB source. 
B. Materials 
1.Compounds Studied: Two degradation products of the fungicide 
benomyl (I), methyl 2-benzimidazolecarbamate (HBC) (II) and 
3-butyl-2,4-dioxo[1,2-a]-s- triazinobenzimidazole (STB) (III) 
were studied (structures are shown in Figure 5). MBC and STB 
of analytical grade purity were prepared at Vineland Research 
Station from Benlate 50% WP as described in (78) and (79) 
respectively. Purity was confirmed by HPLC (65), Proton NMR 
and Mass spectral analyses. 
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2.Solvents: Acetonitrile and methanol used for preparation of 
sample solutions and as part of the HPLC mobile phase were 
HPLC grade from Caledon Laboratories Ltd., Georgetown, 
Ontario. 
3.Chemicals: Disodium hydrogen phosphate (Na 2HP0 4 ) and 
potassium dihydrogen phosph~te (KH 2P0 4 ) used in buffer 
preparation were of reagent grade purity from BDH Chemicals 
Ltd., Poole, England. 
4.Buffer solutions: Buffer solutions for use in the mobile 
phase and in the sample solvent were prepared by adding 
individually prepared solutions of Na ZHP0 4 and KH 2P0 4 of a.OiM 
concentration in a 3:2 (v/v) ratio to obtain final buffer pH 
of 7.00+/- 0.02. 
Buffer solutions used in the study on buffer strengths 
were prepared as follows: 1.ZM buffer by dissolving 0.72 moles 
of Na 2HP0 4 and 0.48 moles of KH ZP0 4 to one Liter with glass 
distilled water, O.70M buffer by mixing 0.70M individually 
prepared solutions of Na 2HP0 4 and KH 2P0 4 in a ratio 3:2 (v/v) 
to obtain pH of 7.00+/-0.02. Buffers of 0.07M and 0.007M 
concentrations were prepared by successive dilutions of 0.7M 
buffer-at pH 7.80+/- 0.02. 
Buffer solutions for the pH study were prepared by 
adding 0.07M ind~vidually prepared solutions of Na 2 HP0 4 and 
KH 2P0 4 in suitable proportions to obtain pH 5.00+/-0.02, 
6.00+/-0.02, 7.00+/-0.02 and 8.00+/-0.02. 
5.Stock Solutions: Stock solutions of the analytes MBC and STB 
used in the preparation of sample solutions were prepared as 
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follows: 
100 ~g/mL STB stock solution was prepared by dissolving 25 mg 
of STB in 250 mL of acetonitrile. The 20 ~g/mL, 10 ~g/mL and 5 
pg/mL stock solutions were prepared by diluting 20 mL, 10 mL, 
and 5 mL of the 100 pg/mL STB stock solution respectively to 
100 mL with acetonitrile. 
100 pg/mL MBC stock solution was prepared by dissolving 25 mg 
of MBC in 250 mL of methanol. The 20~g!mL, 10pg/mL, and 5 
pg/mL stock solutions were prepared by diluting 20 mL, 10 mL, 
and 5 mL of the 100 pg/mL MBC stock solution respectively to 
100 mL with methanol. 
C. HPLC Experiments 
1. General Procedure 
For each factor studied, sample solutions of varying 
compositions were prepared in duplicate in 100 mL volumetric 
flasks. Sample solutions (detailed methods of sample 
preparation are outlined in C4) were injected onto the column 
(operating conditions are outlined in C5)c' and results were 
analysed by measuring retention time, peak height, peak width, 
peak area and peak symmetry as criteria, as outlined in C6. 
The major part of the study was carried out on the HP-HPLC 
unit. For analysis of each series of samples, sample solutions 
were injected using four different volumes of 10, 50, 100, and 
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200 ~L on the HP-HPLC. Four additional studies were performed 
on the PE-HPLC unit. They included the studies on the 
influence of percentage of acetonitrile and methanol in the 
range from 5 to 30%, study on the influence of pH increase at 
0.06M buffer, and the study on the influence of buffer 
strengths while maintaining 35% acetonitrile. A detailed list 
of the remaining PE-HPLC studies is shown in the Appendix I. 
2. Composition of the Sample Solutions 
The basic composition of the sample solutions in this 
study was 5 pg/mL STB, 5 ~g/mL MBC, 5% CH 3 CN, 5% CH30H, 10% of 
0.07 M Phosphate buffer (pH 7), and 80% H20. This composition 
was chosen for two reasons: 1) It was similar to the 
composition of the mobile phase. The lower percentage of CH 3 CN 
in the sample solvent than in the mobile phase was chosen to 
allow for the variation in the sample solvent composition for 
CH30H, pH, and buffer strength, without significant influence 
of a larger percentage of acetonitrile. 2) The presence of 
CH 3 CN was chosen to study the concentration influence of the 
common organic solvent that is the same as in the mobile 
phase. 
The purpose of CH30H was also two fold. It was chosen to 
study the influence of the most widely used organic solvent 
that is different from the mobile phase solvent, and secondly, 
it was used in the preparation of MBC stock solutions. 
The concentration of buffer was chosen to approximate 
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mobile phase composition and to study how buffer 
concentrations and therefore ionic strength, and pH affect 
chromatographic performance. It was also of interest to 
compare the sample solvent effects to those observed by Chiba 
and Singh (65) and Carbas et ale (80) for the mobile phase. 
3. Preliminary Studies to Determine the Optimal Mobile Phase 
Composition 
Optimization of the mobile phase composition was carried 
out by varying the composition of acetonitrile and buffer 
strength. Five mobile phase compositions were examined for 
their separation efficiencies by using resolution as criteria. 
They were 40% CH 3 CN and 10% buffer, 38% CH 3 CN and 8% buffer, 
35% CH 3 CN and 10% buffer, 30% CH 3 CN and 10% buffer, and 25% 
CH 3 CN and 5% buffer. The mobile phase consisting of 35:10:55/ 
CH 3 CN-0.07M pH 7 buffer-water v/v, was found to give best 
performance. 
4. Factors Studied for Their Influence on the RP-HPLC 
Performance 
1). Effect of Acetonitrile Concentration in the Sample Solvent 
Series la(i-vii) solutions varied in acetonitrile 
concentrations from 5 to 30%. Their buffer concentration was 
kept constant at O.06M. Table IVa lists composition of each 
Sol'n. No. 
(i) 
( i'\ ,I, 
(i ii) 
(iv) 
(v) 
(vi 
(vi) 
Sol'n. No. 
("\ 
" (i i) 
(i i i) 
( iv) 
%CH..,CN j 
5.0 
1 0.0 
12.5 
15.0 
20.0 
30.0 
5.0 
25.0 
35.0 
50.0 
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Table IVa 
Composition of Sample Solutions for Series 1 a(i-vii) 
in 1) Acetonitrile Concentration Study 
%C~OH 
5.0 
5.0 
5.0 
5.0 
5.0 
5.0 
5.0 
% 1.2M Buffer 
at pH 7 
5.0 
5.0 
5.0 
5.0 
5.0 
Table IVb 
[STB] 
llg/m L 
5.0 
5.0 
5.0 
5.0 
5.0 
5.0 
5.0 
Composition of Sample Solutions for Series 1 b(i-iv) 
in 1) Acetonitrile Concentration Study. 
5.0 
5.0 
5.0 
5.0 
% 0.07M Buffer 
at pH 7 
1 0.0 
10.0 
10.0 
1 0.0 
[STB] 
llg/m L 
5.0 
5.0 
5.0 
5.0 
[MBC] 
Ilg/mL 
5.0 
5.0 
5.0 
5.0 
5.0 
5.0 
[MBC] 
llg/m L 
5.0 
5.0 
5.0 
5.0 
85. C 
80.0 
77.5 
70.0 
65.0 
60.0 
8 0.0 
60.0 
5 0.0 
35.0 
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of the seven solutions. A 50 pL sample of each of these 
solutions was injected in triplicate to the PE-HPLC and 
results were analysed. The composition and the chromatographic 
data for the second series of solutions analysed on the 
PE-HPLC are shown in Appendix I. 
Series lb solutions we~e analysed by the HP-HPLC. These 
solutions varied in acetonitrile concentrations from 5 to 50% 
with the analyte concentration of 5 ~g/mL for MBC and STB. 
Their buffer concentration was reduced to O.007M to equal the 
mobile phase composition and to eliminate the possibility of 
buffer precipitation at high acetonitrile concentrations. 
Table IVb lists the complete camposition of solutions for 
series lb(i-iv). Three more series of solutions lc(i-iv), 
ld(i-iv), and le(i-iv), differing only in the concentration of 
analytes, were prepared. The analyte concentrations were 
lpg/mL, 0.5pg/mL, and 0.25 pg/mL, respectively. 
2) Effect of Methanol Concentration in the Sample Solution 
Six solutions in series 2a(i-vi) were prepared to study 
the influence of methanol concentration in the sample solvent 
on the chromatographic performance. These solutions varied in 
methanol concentrations from 5 to 25%. The buffer 
concentration in these solutions was O.06M. The complete list 
of sample compositions for series 2a is shown in table Va. A 
50 pL aliquot of each of the solutions from series 2a was 
analysed on the PE-HPLC. The composition and the 
chromatographic data for the second series of solutions 
Solin. No. %CH1~N 
( i) 5.0 
(ii) 5.0 
(i i i) 5.0 
(iv) 5.0 
(v) 5.0 
(vi) 5.0 
Solin. No. 
( i) 5.0 
(ii) 5.0 
(i i i) 5.0 
(iv) 5.0 
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Table Va 
Composition of Sample Solutions for Series 2a(i-vi) 
in 2) Methanol Concentration Study 
%CH3OH % h2M Buffer [STB] 
at pH 7 IlgJmL 
5.0 5.0 5.0 
1 0.0 5.0 5.0 
1 2.5 5.0 5.0 
15.0 5.0 5.0 
20.0 5.0 5.0 
25.0 5.0 5.0 
Table Vb 
Composition of Sample Solutions for Series 2b(i-iv) 
in 2) Methanol Concentration Study. 
%C~c)H 
5.0 
25.0 
35.0 
50.0 
% 0.07M Buffer 
at pH 7 
1 0.0 
10.0 
1 0.0 
1 0.0 
[STB] 
IlgJm L 
5.0 
5.0 
5.0 
5.0 
[MBC] 
IlgJm L 
5.0 
5.0 
5.0 
5.0 
5.0 
:: 1"\ ~.,U 
[MBC] 
1l9/m L 
5.0 
5.0 
5.0 
5.0 
%HP 
85.0 
80.0 
77.5 
75.0 
70.0 
6 5 ~ 0 
80.0 
60.0 
50.0 
35.0 
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analysed on the PE HPLC are listed in Appendix I. 
Series 2b(i-iv) samples were analysed on the PE-HPLC. In 
these solutions methanol concentrations varied from 5 to 50%. 
In this series the buffer concentration in the sample was the 
same as for the mobile phase of 0.007M. The compositions of 
individual solutions for series 2b(i-iv) are listed in Table V 
b. Series 2c(i-iv), 2d(i-iv), and 2e(i-iv) differed in 
composition from 2b(i-iv) only in analyte concentrations which 
were 1 pg/mL, 0.5 pg/mL, 0.25 pg/mL respectively. 
3) Effect of pH of the Sample Solution 
The solutions in series 3a(i-vii) were prepared to study 
the influence of pH in the sample solutions on the 
chromatographic peak profiles of SIB and MBC. For this series 
of solutions the pH of the 1.2M buffer added to each solution 
varied from pH 4.42 to pH 9.10. This series was analysed on 
the PE-HPLC. The composition of individual solutions for 
series 3a(i-vii) are listed in Table VIa. A 50 pL aliquot of 
each solution was injected. For the second series of solutions 
analysed on the PE-HPLC, the solution composition and the 
chromatographic results are shown in Appendix I. 
For the analysis on the HP-HPLC, solutions differing 
only in the analyte concentration were prepared. For series 
3b(i-iv), analyte concentrations were 5 pg/mL for both STB and 
MBC. Complete compositions of series 3b(i-iv) samples are 
listed in Table VIb. Series 3c(i-iv), 3d(i-iv), and 3e(i-iv) 
had the same compositions as series 3b(i-iv) except analyte 
Sol'n. No. %CH3CN 
(i) 5.0 
(ii) 5.0 
(i ii) 5.0 
C \ IV, 5.0 
(v) 5~O 
(vi 5.0 
(vi) 5.0 
Sol'n. No. %CH 3CN 
( i) 5.0 
(ii) 5.0 
(i i i) 5.0 
(iv) 5.0 
46 
Table Via 
Composition of Sample Solutions for Series 3a(i-vii) 
in 3) pH Study 
%CH3OH 0/0 1-.2M Buffer [STB] 
Ilg /mL 
5.0 5.0 at pH 4.42 5.0 
5.0 5.0 at pH 5.95 5.0 
5.0 5.0 at pH 6.50 5.0 
5.0 5.0 at pH 6.74 5.0 
;::; n 
~. v 5.0 at pH 7.40 5.0 
5~O 5.0 at pH 7.98 5.0 
5.0 5.0 at pH 9.10 5.0 
Table Vlb 
Composition of Sample Solutions for Series 3b(i-iv) 
in 3) pH Study. 
%C~OH % 0.07M Buffer 
5.0 10.0 at pH 5.0 
5.0 10.0 at pH 6.0 
5.0 10.0 at pH 7.0 
5.0 10.0 at pH 8.0 
[STB] 
Ilg /mL 
5.0 
5.0 
5.0 
5.0 
[MBC] 
j.l,g/mL 
5.0 
5.0 
5.0 
5.0 
5.0 
5 n . ~
5.0 
[MBC] 
Ilg/mL 
5.0 
5.0 
5.0 
5.0 
%H2 0 
85.0 
85.0 
85.0 
85.0 
85.0 
8 5 ~ 0 
85.0 
80.0 
80.0 
80.0 
80.0 
Sol'n. No. %CHPN 
( i) 35.0 
(ii) 35.0 
(i i i) 35.0 
( iv) 35.0 
(v) 35.0 
Sol'n. No. 
( i) 5.0 
(ii) 5.0 
(ii i) 5.0 
(iv) 5.0 
(v) 5.0 
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Table Vila 
Composition of Sample Solutions for Series 4a(i-vii) 
in 4) Buffer Strength Study 
%CH3OH % Buffer [STB] 
at pH 7.0 Ilg /mL 
5.0 10.0 at 1.400M 5.0 
5.0 10.0 at a.700M 5.0 
5.0 10.0 at 0.070M 5.0 
5.0 10.0 at 0.OO7M 5.0 
5.0 no buffer added 5.0 
Table Vllb 
Composition of Sample Solutions for Series 4b(i-iv) 
in 4) Buffer Strength Study. 
%C~OH 
5.0 
5.0 
5.0 
5.0 
5.0 
% Buffer 
at pH 7.0 
10.0 at i.200M 
10.0 at 0.700M 
10.0 at 0.070M 
10.0 at 0.007M 
no buffer added 
[STB] 
Jlg/mL 
5.0 
5.0 
5.0 
5.0 
5.0 
[MBC] 
1l9/mL 
5.0 
5.0 
5.0 
~ r. 
::I.v 
5.0 
[MBC] 
Jlg/m L 
5.0 
5.0 
5.0 
5.0 
5.0 
%H (l 
2 
50.0 
50.0 
50.0 
5 O. 0 
60.0 
%H"O i 
8 a. 0 
80.0 
8 a. a 
80.0 
90.0 
48 
concentrations were reduced to 1, 0.5, and 0.25 ug/mL 
respectively. 
4) Effect of Buffer Concentration in the Sample Solution 
Two series of solutions with varying buffer 
concentrations, from ° to 0~14M, were analysed on the PE-HPLC. 
The composition of series 4a(i-iv) samples is listed in Table 
VIla. For the remaining series the composition and the 
chromatographic data are reported in the Appendix I. 
Four series of solutions were analysed on the HP-HPLC. 
The composition of series 4b(i-iv) samples is reported in 
Table VlIb. Series 4c(i-iv), 4d(i-iv), and 4e(i-iv) sample 
solutions varied from 4b only in analyte concentrations, which 
were 1, 0.5, ana 0.25 pg/mL respectively. 
5) Influence of Injection Volume at Increasing Mass 
Four injection volumes of 10, 50, 100, and 200 pL at 
analyte concentrations of 5 pg/mL were studied for the b 
series of samples for each of the above four factors. 
6) Influence of Injecton Volume at Constant Mass 
Four injection volumes of 10, 50, 100, and 200 pL at 
analyte concentrations of 5, 1, 0.5, and 0.25 pg/mL were 
studied for series b, c, a, and e, for each of the four 
factors. 
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5. Operating Parameters 
1) Mobile Phase : The composition of the mobile phase used 
throughout the study was CH 3 CN-H 20-pH 7 buffer, (35:55:10) v/v 
and the system was run isocratically. All mobile phase 
solutions were filtered through 0.45 um membrane filter and 
degassed for 5 minutes under a vacuum. During the analysis on 
HP-HPLC, mobile phase solvents were completely purged with 
helium. 
2) Flow Rate : A mobile phase flow rate of 1 mL/min was used 
for the entire study. 
3) Injection Volume: In PE-HPLC analyses, solutions were 
introduced through a constant volume loop of 10 or 50 pL. In 
the HP-HPLC an automatic sampler with variable volume injector 
was used allowing unattended operation of the instrument. 
Injection volumes were varied by computer command from 10 to 
200 pL. When different concentrations of analytes were 
involved, analyses were carried out in the increasing order of 
concentrations to minimize potential errors due to carryover 
of previously injected samples. 
4) Recorder Settings : For PE-HPLC analyses the chart speed 
was set to 0.5 em/min and voltage setting was 1 millivolt full 
scale. For analyses on HP-HPLC chart speed was set to 1 
em/min. 
5) Detector Settings : The detection wavelength was 280 nm 
throughout. For the PE-HPLC detector, the response mode was 
50 
normal with FS absorbance of O.lAU for 50 ~L injectons and 
0.02AU for 10 ~L injections. For the HP instrument absorbance 
range was 280, 140, 70, and 14 mAU for injection volumes of 
200, 100, 50, 10 ~L, respectively. The absorbance spectrum 
from 340 to 240 nm was recorded at the apex of each 
chromatographic peak to obs~rve possible changes in absorbance 
profiles due to variations in sample composition. 
6) Temperature: Analyses were carried out at room temperature 
(22-25 0 C) on the PE instrument and at 40°C on the HP-HPLC. 
6. Analysis of Chromatographic Results 
1) Criteria Used to Assess the Chromatographic Performance 
a. Retention Time defined as the time taken to reach the 
apex of the peak, where the apex is the point at which the 
first derivative changes from positive to negative. 
b. Peak Height: defined as the perpendicular distance from 
the apex to the baseline. 
c. Peak Width : defined as a time span between up and down 
slope of the peak at half height and is calculated from the 
equation 0.3T + 0.7A/H where T = time between peak inflection 
points, A = corrected area, and H = corrected height. If 
inflection point is not found peak width is calculated as A/H. 
d. Peak Area : The start of the area count occurs when (1) the 
first derivative of two consecutive data points is greater 
than the slope threshold, (2) the second derivative is 
51 
positive, and (3) the end of the area count occurs when the 
first and second derivatives are respectively smaller than the 
slope and the curvature threshold. 
e. Peak Symmetry: calculated from the equation: 
eq. [91 
where: A1 = area between start of the peak and front inflection 
point; A2 = area between front inflection point and peak apex; 
A3= area between apex and rear inflection point; A4= area 
between rear inflection point and end of peak. Above 
definitions were obtained from HP Operating Manual. 
2) Plots 
Plots of retention time, peak height, and peak width 
verses the change in the solution composition were made for 
each of the factors studied. 
D. Additional Experiments 
1. pH Measurements 
The pH values of the buffer solutions before adding 
organic solvents and the apparent pH* values of the sample 
solutions as prepared with the presence of acetonitile and 
methanol at various compositions were measured. Results are 
reported in Table XX. 
52 
2.UV Absorbance Measurements 
To study the possible effects due to the composition 
changes of the sample solvent on the UV absorbance profiles of 
STB and MBC, individual solutions containing only STB or MBC 
were prepared. These soluti9ns were in every other respect 
same as solutions from C3(1-4). A UV scan of each solution was 
recorded from 340 to 240 nm. The UV data are shown in Table 
XXI. 
3.Mass Spectral Anlyses 
Both compounds were analysed by EI and FAB mass spectral 
technigue in hope to learn more about their hydrogen bond 
character. 
4. Proton NMR and Infra Red Spectral Analyses 
The above analyses were attempted in hope to gain more 
information on the sample solvent interaction, but due to low 
solubility of analytes and only in highly polar solvents no 
useful information was obtained. 
E. Linearity of Detector Response and Reproducibility 
For MBC, linear response was established for 5 ~g/mL 
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solutions from 10 pL up to 200 ~L injection volume with 
correlation coefficient of 0.99967. For STB at 5 pg/mL 
response was linear from 10 ~L up to 200 pL injection volume 
with coefficient of correlatrion of 0.99953. 
The coefficient of variation in the injection 
reproducibility on PE-HPLC, for six consecutive injections of 
solution (i) from series la, was 0.6% for retention time and 
1.0% for peak heights. For HP-HPLC, the reproducibilty error 
for 24 injections at 10 ~L injection volume for STB in series 
1b was 0.1% for retention time, 0.7% for peak height, 0.5% for 
peak width and 2.5% for peak area. 
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III. Results 
The effects of the sample composition in the RP-HPLC 
analysis on the peak profiles of two carbamate compounds STB 
and MBC were examined. These were: effect of methanol 
increase, effect of acetoni~rile increase, change in the pH 
and increase in buffer concentration. The effects were studied 
by examining changes in retention times, peak areas, peak 
heights, peak widths and peak symmetries at varying sample 
compositions. The effects of injection volume at increasing 
mass and at constant mass were also studied. 
Data from duplicate samples, each injected in triplicate 
were obtained from the HP-85 computer for HP-HPLC analyses and 
were obtained manually for PE-HPLC analyses. Data were further 
reduced by calculating mean and standard deviation for 
triplicate injections. Results are listed in Tables VIII-XIX, 
and plots and chromatograms illustrating observed trends are 
shown in Figures 6-61. 
A. Effect of Acetonitrile Concentration in the Sample Solution 
on the Chromatographic Peak Profile 
1.Analysis on PE-HPLC 
There was no pronounced influence on the retention time 
of STB or MBC as acetonitrile concentration was increased from 
Table VIII* 
Chromatographic Results for STB and MBC Whorl [CH3CN] 
Increases from 5 to 30% at 0.06M Buffer Conconlration 
[CH3CN] Retention Time (min) Peak Height (cm) 
% STB MBC STB MBC 
5.0 3.42±.02 4.48±.02 10.10:1.10 9.15±.05 
1 0.0 3.40±.02 4.50±.00 1 0.60J, 1 0 9.02±.08 
1 2.5 3.40±.00 4.50±.02 10 .. 181:.06 9.03±.05 
15.0 3.42±.02 4.50±.02 10.021.08 8.85±'05 
20.0 3.40±.00 4.50±.00 9.85:1:..07 8.80±.00 
25.0 3.40±.00 4.50±.00 9.90±.10 8.82±.10 
30.0 3.40±.00 4.48±.02 9.88±.10 8.54±.07 
*-50)lL injection volume 
tTl 
tTl 
56 
5 to 30%, at 50 ~L injection volume and 0.06M buffer 
concentration (Table VIII). The peak height, however, 
decreased by 6.7% for MBC and by 2.3% for STB. 
2.Analysis on HP-HPLC 
Two major differences from the PE study were: 1) The 
buffer concentration was reduced from 0.06 to O.007M to equal 
that of the mobile phase; 2) The acetonitrile concentration 
range was increased to 50%, to include the concentration 
higher than that in the mobile phase of 35%. 
1) At Constant Mass of Analyte Injected 
Retention Time As the concentration of acetonitrile in the 
sample solvent increased from 5 to 50%, the retention time of 
the STB peak decreased (Table IXa). The reduction in retention 
time was enhanced by an increase in the injection volume. For 
10, 50, 100, and 200 ~L injections, retention times decreased 
by 1.9, 6.9, 9.8, and 11.8% respectively. At the same solution 
composition, the retention times of the analytes increased 
with the the increase in the i~jection volume but the 
increases became less pronounced as the concentration of 
acetonitrile in the sample solvent became greater, as can be 
observed in Figures 7. At 5% acetonitrile, retention times 
were 2.271, 2.366, 2.440, and 2.575 minutes and at 50% 
acetonitrile, retention times were 2.202, 2.203, 2.20, and 
2.271 minutes for 10, 50, 100, and 200 uL injections, 
respectively. 
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Table IXa 
Chromatographic Results for STB when [CH1CN] in the Sample Solvent increases from 5 to 50% and Injected Mass of Analytes Sta s Constant at Increasing Injection Volume. 
CH3CN CONC. RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
% TIME (min) (mAUs) (mAU) (min) 
10 /J.L @ 5/J.g/mL 
5 2.271±.001 77±1 9.84±.08 0.109±.001 0.36±.01 
5 2.272±.O01 77±1 9.69±.01 0.116±.OO1 0.37±.O1 
25 2.255±.003 83±4 9.01±.15 0.128±.001 0.36±.O1 
25 2.256±.003 81::::1 8.95±.01 0.126±.001 0.36±.O1 
35 2.241±.OO3 85±4 8.44±.10 0.139±.005 0.35±.01 
35 2.241±.002 82±1 8.28±.08 0.138±.004 0.36±.O1 
50 2.227±.002 76±3 7.21±.06 0.151±.003 0.41±.01 
50 2.230±.002 76±1 7.19±.03 0.154±.003 0.42±.01 
50 /J.L @ 1j.1.gimL 
5 2.366:1:.002 89:=9 ,2.47:J:.02 OJ)96::..001 0.32=.01 
5 2.364±.001 92±6 12.51±.08 O.111±.OO5 0.31±.02 
35 2.274±.001 87±1 8.97±.06 0.139±.001 0.41±.01 
35 2.276±.001 87±1 9.12±.O4 0.138±.001 O.41±.Oi 
50 2.203±.OO3 80±2 5.39±.03 0.21 O±.01 0 0.58±.01 
50 2.206±.001 80±2 5.37±.03 0.219±.009 0.59±.O2 
100/J.L @ .5llg/mL 
5 2.440±.001 90±1 12.57±.07 0.098±.001 0.30±.01 
5 2.441±.003 92±3 12.60±.10 0.099±.002 0.29±.01 
35 2.319±.002 89±1 8.83±.02 0.146±.002 0.99±.01 
35 2.319±.002 88±1 8.76±.05 0.145±.O01 0.99±.01 
50" 2.170±.020 4.5 0.79±.08 
50* 2.180±.006 4.1 0.74±.01 
200/J.L @ .25/J.g/mL 
5 2.575±.002 83±1 11.45±.08 0.099±.001 0.29±.01 
5 2.575±.002 86±6 11.61±.12 0.101±.003 0.28±.01 
35 2.413±.003 80±2 7.2S±.05 O.164±.003 0.62±.03 
35 2.414±.005 SO±1 7.17±.12 0.163±.004 0.63±.01 
50 2.271±.009 50±4 2.55±.09 0.251±.046 0.54±.02 
50 2.230±.020 1.19±.01 0.77±.06 
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Table IXb 
Chromatographic Results for MBC when [CH3CN1 in the Sample Solvent increases from 
5 to 50% and Injected Mass of Analytes Stays Constant at Increasing Injection Volume. 
CH3CNCONC. RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
% TIME (min) (mAUs) (mAU) (min) 
10 J..Ll @ 5J..Lg/ml 
5 3.323±.003 104±6 9.16±.11 0.163±.O10 0.42±.03 
5 3.326±.001 98±4 8.92±.19 0.156±.001 0.42±.O1 
25 3.329±.003 104±"1 8.62±.09 0.169±.003 0.40±.02 
25 3.332:::.003 106:::1 8.72±.01 0.170± 0 0.41± 0 
35 3.317±.002 107±3 8.60±.08 0.176:::.005 0.411.01 
35 3.320±.003 10512 8.47±.16 0.178±.002 0.40±.O1 
50 3.316±.004 101±3 8.15:::.06 0.183±.007 0.42±.01 
50 3.320±.002 104±8 8.46±.61 0.188:::.010 0.41:t.04 
50 III @ 11lg/ml 
!:) 3~34C~ .. OO2 114±1 11.38±.O5 O.143±~OO1 0.39=. .. 01 
5 3.340±.001 113±4 11.34±.07 0.145±.005 0.40±.01 
35 3.284±.002 114±3 8.73±.09 0.143±0 0.46±.02 
?£:: 3.284±.002 114±1 8.81:::.02 0.191±.005 0.45:::.01 v .... 
50 3.25f±.OO1 114±2 7. 64±.08 0.21 O±.01 0 0.48±.01 
50 3.253±.003 109±6 7.43±.22 0.218±.005 0.51±.03 
100J..Ll @ .5J.1.g/ml 
5 3.405±.001 112±3 11.87±.09 0.135±.001 0.38±.O1 
5 3.404±.001 114±3 11.88±.07 0.136±.004 0.38±.O1 
35 3.318:::.001 114±2 7.89±.02 0.213±.005 0.54±.02 
35 3.319±.002 113±1 7.84±.03 0.215±.006 0.53±.O1 
50 3.265±.003 114±1 5.76±.10 0.281±.O19 0.66±.O1 
50 3.280±.O10 113±2 5.73±.03 0.265 ±.012 0.72±.09 
200J..Ll @ .25J..Lg/ml 
5 3.532±.003 117±3 12.211.05 0.134±.003 0.37±.O1 
5 3.533±.002 115±3 12.73:::.03 0.132±.003 0.39±.O1 
':I'" 
..,0 3.388:::.007 11912 6.60±.10 O.290±.O30 0.62±.04 
35 3.4261.003 115±1 6.30±.10 0.270±.030 0.61±.O1 
50 3.320±.040 119±3 3.66±.05 0.398±.002 0.67±.06 
50 3.290±.O10 3.59±.07 0.65± 0 
59 
Figure 6: Chromatograms of STB (1) and MaC (2) tor Constant Mass Study Showing the Effects of the 
Increasing Acetonitrile Concentration in the Sample Solvent. 1) 5% CH3CN; 2) 35% CH3CN; 
3) 50% CH3CN. 
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Figur~ 7: Plot of Retention Time vs. Acetonitrile Concentration in the Sample Solvent 
for STB at Constant Analyte Mass for 10, 50. 100 and 200 J..LL 
Injections. 
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Figure 8: Plot of Retention Time vs. Acetonitrile Concentration in the Sample Solvent 
for MBC at Constant Analyte Mass for 10, 50,100, and 200 f..I.L 
Injections. 
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Figure 9: Plot of Peak Height vs. Acetonitrile Concentration in the Sample Solvent 
for STB at Constant Analyte Mass for 10. 50.100 and 200 ilL 
Injections. 
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Figure 11: Plot of Peak Width vs. Acetonitrile Concentration in the Sample Solvent 
for STB at Constant Analyte Mass for 10, 50,100 and 200 fJ.L 
Injections . 
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Figure 12: Plot of Peak Width vs. Acetonitrile Concentration in the Sample Solvent 
for MBC at Constant Analyte Mass for 10, 50,100, and 200 fJ.L 
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A decreasing trend in the retention time with the 
increase in the acetonitrile concentration was also observed 
for MBC but to a somewhat smaller extent (Figure 8). Decreases 
of 1.0, 2.7, 4.1, and 6.0% were observed for 10, 50, 100 and 
200 pL injection volumes. Here again retention time increased 
as the injection volume increased, for the same solution 
composition, and the increase became less pronounced as 
acetontrile concentration increased. Complete results are 
listed in Table rXb. 
Peak Height The increase in the acetonitrile concentration 
also had strong influence on the peak heights of STB (Figure 
9) and MBC (Figure 10). For both analytes peak heights 
decreased with the acetonitrile increase. The decrease in the 
peak height was more prominent at larger injection volumes. 
For S T B , peak heights decreased by~2 6. 7 i 5 6 • 9, 6 4. 2 , and 
77.7%, while for MBC, decreases were 8.2, 33.7, 51.6, and 
70.9% for 10, 50, 100, and 200 pL respectively. The peak 
height influence was greater for STB than MBC, especially at 
lower acetonitrile concentrations. 
Peak Width The peak widths of both analytes increased with 
the increase in acetonitrile pe±centage at all fo~r injection 
volumes (Tables rXa and rXb). The increases became greater for 
larger injection volumes as can be observed in Figures 11 and 
12. An interesting point was that for STB at 5% acetonitrile, 
peak widths were the same for all four injection volumes while 
for MBC at 510 acetonitrile', an actual decrease in the peak 
width was observed with the increase in the injection volume. 
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At 50% acetonitrile, however, a significant increase in the 
peak widths was observed. For MBC at 5% acetonitrile peak 
widths were 0.162, 0.143, 0.135, and 0.134 minutes, while at 
50% acetonitrile peak widths were 0.170, 0.219, 0.281, and 
0.398 minutes, for 10, 50, 100, and 200 ~L injections, 
respectively. 
Peak Area The peak areas for STB remained constant from 5 to 
35% acetonitrile, and decreased for 50% acetonitrile. The 
decrease became more pronounced as the injection volume 
increased. A reason for this was that a larger proportion of 
STB was eluted in the split peak as the injection volume 
increased. The area of the M~C peak remained constant at all 
acetonitrile concentrations at all four injection volumes 
(Table IXa and IXb). 
Peak Symmetry A significant increase in the peak symmetry 
(which is an improvement) was observed for both analytes with 
the increase in the acetonitrile concentration. The increase 
was somewhat larger for STB than MBC as can be observed in 
Tables IXa and IXb. 
2) At Increasing Mass of Analyte Injected 
Four sets of experiments were performed. For each 
experiment, anlyte concentrations were constant at 5 pg/mL as 
the injection volume was increased from 10 to 50, 100, and 200 
pL. Complete chromatographic results are listed in Table Xa 
for STB and Table Xb for MBC. To compare these results to 
those of the constant mass study, the peak area and the peak 
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TableXa 
Chromatographic Results for STB when [C~ CN] in the Sample Solvent increases from 
S to SO% and Injected Mass of Analytes I reases with Increasing Injection Volume. 
CH3CN CONC. RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
0/0 TIME (min) (mAUs) (mAU) (min) 
10 J..ll @ 5J..lg/ml 
5 2.27H.OOi 77±i 9.84±.08 0.109±.001 0.36±.01 
5 2.272±.001 77±i 9.69±.01 0.116±.001 0.37±.01 
25 2.255±.003 83±4 9.0H.iS 0.i28±.001 0.36±.01 
25 2.256±.003 8H1 8.95±.01 0.i26±.001 O.36±.O1 
35 2.24H.003 85±4 8.44±.10 O.139±.OOS O.35±.O1 
35 2.24H.OO2 82±1 8.2B±.08 O.138±.OO4 O.36±.O1 
50 2.227±.OO2 76±3 7.2H.06 O.15H.OO3 O.4H.01 
SO 2.230±.O02 76±i 7.19±.O3 O.154±.O03 O.42±.O1 
50 J..ll @ 5J..lg/ml 
5 2.378±.OO2 95±5 12.20±.10 0.106±.OO4 O.28±.O1 
5 2.376±.00i 9S±3 12.05±.08 O.108±.OO3 O.29±.O2 
25 2.329±.OO1 92±1 10.62±.O3 0.123±.001 O.35±.O1 
?J:: 
-.... 
2.326±.OO1 9H1 10.57±.O4 O.119±.004 O.38±.O3 
35 2.285±.OO1 92±1 B.68±.OS O.153±.001 O.38±.01 
35 2.286±.001 97±3 S.70±.iO O.159±.OO3 O.36±.O3 
50 2.224±.001 88±2 5.24±.04 O.249±.003 0.6H.02 
50 2.225±.OO4 89±1 5.30±.06 O.255±.007 0.S2±.07 
100J..ll @ 5J..lg/ml 
S 2.4S7±.OO4 92±1 12.1H.01 0.103±.00i O.28±.Oi 
S 2.458±.O02 92±1 ii.96±.08 0.i04±.001 0.28±.Oi 
25 2.400±.001 94±i i0.77±.03 O.i24±.001 0.34±.01 
25 2.396±.O01 93±2 1 0.72±.1 0 0.122±.OO3 O.35±.O1 
35 2.335±.OO2 93±2 8.58±.04 O.i57±.002 0.45±.O1 
3S 2.335±.003 93±1 8.40±.01 0.159±.001 0.45±.01 
50 2.229±.001 8H2 4.03±.O2 0.286±.O06 O.62±.Oi 
50 2.244±.O09 8H2 4.03±.O2 0.289±.00i 0.62±.O1 
200J..lL @ 5J..lg/mL 
5 2.S90±.003 93±i 11.52±.01 0.109±.OO1 O.28±.O1 
5 2.590±.003 92±1 i1.S2±.03 0.109± 0 0.28±.O1 
25 2.S05±.003 94±i 10.46±.01 0.126±.OO1 a.3S±.01 
25 2.S05±.001 93±1 10.44±.O4 O.126± 0 O.3S±.01 
35 2.4i7±.001 93±1 6.95±.04 0.195±.OO1 0.63±.01 
35 2.418±.OO1 95±1 7.00±.O4 0.197±.OOS O.62±.01 
SO* 1.809±.OOi 16±1 1.76±.O1 O.11f±.DOi 
50* 1.902±.OO1 2H1 1.88±.O2 O.158±.OO7 
SO" 2.283±.006 S6±1 2.66±.01 O.298±.OOS 0.62±.O6 
SO· 1.S08±.OO4 16±1 1.77±.02 O.12S±.017 
SO· 1.900±.004 22±1 1.91±.O1 O.16S±.001 
SO~ 2.280±.003 S7±1 2.68±.01 O.301±.OO2 0.SH.06 
,. denotes split peaks 
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TableXb 
Chromatographic Results for MBC when [CH3CN] in the Sample Solvent increases from 
5 to 50% and Injected Mass of Analytes Increases with Increasing Injection Volume. 
CH3CN CONC. RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
% TIME (min) (mAUs) (mAU) (min) 
10 J,l.L @ 5J,1.g/mL 
5 3.323±.003 104±6 9.16±.11 0.163±.010 0.42±.03 
5 3.326±.001 98±4 8.92±.19 0.156±.001 0.42±.01 
25 3.329±.003 104±1 8.62±.09 0.169±.003 0.40±.02 
25 3.332±.OO3 106±1 8.72±.01 0.170± 0 0.41± 0 
35 3.317±.002 107±3 8.60±.O8 O.176±.OO5 0.41±.01 
35 3.320±.OO3 105±2 8.47±.16 0.178±.002 0.40±.01 
50 3.316±.004 101±3 8.15±.06 0.183±.007 0.42±.01 
50 3.320±.OO2 104±8 8.46±.61 0.188±.010 0.41±.04 
50 J,l.L @ 5J,1.g/mL 
5 3.393±,002 122±5 10.84 ±.41 0.182±.013 O.39±.O1 
5 3.393±.001 125±5 10.44 ±.15 0.172±.003 0.36±.02 
25 3.367±.001 117±0 8.86±.01 0.196±.001 0.38±.01 
25 3.366±.003 117±1 8.87±.04 O.197±.OO2 0.38±.01 
35 3.343±.002 120±2 8.20 ±.10 0.216±.007 0.39±.02 
35 3.345±.002 120±5 8.10±.10 0.216±.006 0.41± 0 
50 3.316±.002 117±1 7.14±.03 0.243±.015 0.45±.01 
50 3.319±.004 116±1 7.12±.01 0.247±.002 0.45±.01 
100J,l.L @ 5J,1.g/mL 
5 3.458±.004 120± 1 10.45 ± .01 0.165±.001 0.34 ± .01 
5 3.461±.003 120± 1 10.43 ± .04 0.167±.006 0.34 ± .01 
25 3.419±.002 122±5 8.77± .03 0.202±.006 0.37 ± .02 
25 3.414±.002 121 ± 1 8.69± .01 0.206±.001 0.38 ± .01 
35 3.378±.002 122±2 7.47± .06 0.239±.009 0.45 ± .02 
35 3.373±.003 122± 1 7.42± .02 0.249±.001 0.44 ± .01 
50 3.323±.001 121 ± 2 5.51 ± .01 0.342±.OO9 0.54 ± .01 
50 3.374±.009 121 ± 2 5.54± .04 0.343±.002 0.59 ± .07 
200J,l.L @ 5J,1.g/mL 
5 3.571±.004 120± 1 10.11 ± .04 0.167±.O01 0.31± 0 
5 3.572±.002 120± 1 10.09 ± .03 0.167±.001 0.31±.01 
25 3.498±.002 120± 1· 7.94 ± .01 0.227±.001 0.42± 0 
25 3.497±.002 120± 1 7.93 ± .01 0.227±.001 0.42±.01 
35 3.432±.003 121 ± 1 5.90 ± .03 0.322±.002 0.53±.01 
35 3.433±.002 123±4 5.98 ± .08 0.321±.005 0.53±.01 
50 3.329±.003 122±2 3.54 ± .03 0.530±.O40 0.68±.07 
50 3.322±.005 123± 1 3.56 ± .01 0.569± 0 0.63±.06 
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figure 13: Chromatograms of STB (1) and MBC (2) for Increasing Mass Study Showing the Effects of 
the Increasing Acetonitrile Concentration in the Sample Solvent. ') 5% CH3CN; 2) 25% 
CH3CN; 3) 35% CH3CN; 4) 50% CH3CN. 
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Figure 14: Plot of Retention Time vs. Acetonitrile Concentration in the Sample Solvent 
for STB at Increasing Analyte Mass for 10, 50,100 and 200 ~L 
Injections. 
2.6 
10~L 0 
50~L 
100llL 
2.5 200llL 
2.4 
2.3 
Flaure 15: Plot of Retention Time vs. Acetonitrile Concentration in the Sample Solvent 
for MBC at Increasing Analyte Mass for 10, 50,100, and 200 ~L 
Injections. 
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Figure 16: Plot of Peak Height vs. Acetonitrile Concentration in the Sample Solvent 
for STB at Increasing Analyte Mass for 1 0, 50, 100 and 200 III 
Injections. 
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Figure 17: Plot of Peak Height vs. Acetonitrile Concentration in the Sample Solvent 
for MBC at Increasing Analyte Mass for 10, 50,100, and 200 III 
Injections. 
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Figure 18: Plot of Peak Width vs. Acetonitrile Concentration in the Sample Solvent 
for STB at Increasing Analyte Mass for 10, 50, 100 and 200 J.Ll 
Injections. 
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Figure 19: Plot of Peak Width vs. Acetonitrile Concentration in the Sample Solvent 
for MBC at Increasing Analyte Mass for 10,50,100, and 200 III 
Injections . 
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height results were devided by the factor of increase in the 
injection volumes. The resulting chromatographic plots are 
shown in Figure 13. 
Retention Time The retention times of the two analytes were 
influenced in an almost identical way to the constant mass 
study. The decreases of 1.9~ 6.4, 9.0 and 11.8% were observed 
for STB and decreases of 0.2, 2.2, 3.9, and 6.8% in retention 
times were observed for MBC for 10, 50, 100, and 200 ~L 
injections. The decrease was more gradual in the range from 5 
to 25% and became much steeper from 25 to 50% acetonitrile, 
for both analytes studied, as can be seen in Figures 14 and 
15. For 50% acetonitrile in the 200 ~L study, STB was eluted 
in two well defined peaks. The confirmation that the two peaks 
were due to STB was made by the UV scan of each peak. 
Peak Height The peak heights of the two analytes were 
influenced to the same extent as for the constant mass study 
as can be observed in Figures 16 and 17. The decreases in the 
peak heights of STB were 26.3, 56.5, 66.5 and 76.8% while for 
MBC decreases were 8.1, 33.0, 47.1, and 64.9%. 
Peak Width The peak widths increased with the increase in the 
acetonitrile content (Table Xa). At 5 and 25% acetonitrile, 
peak widths for STB were very similar at all four injection 
volumes, but sharply increased at higher acetonitrile 
concentrations (Figure 18). The increasing trend in the peak 
widths was also observed for MBC as can be seen in Figure 19. 
The influence of injection volume on the peak width of MBC 
became more apparent at 25% acetonitrile at which point there 
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was essentially no influence for STB (Figures 18 and 19). 
Peak Area The areas of STB peaks were constant from 5 to 35%, 
and decreased only at 50% acetonitrile. However, this was due 
primarily to the presence of the split peaks (Table Xa). The 
areas of the MBC peaks were not affected at any acetonitrile 
concentrations (Table Xb). 
Peak Symmetry An increase in the peak symmetry was observed 
at increasing acetonitrile concentrations. The increases were 
somewhat smaller for MBC than for STB and became more 
pronounced with an increase in the injection volume (Table Xa 
and Xb). 
B. Effects of Methanol Concentration in the Sample Solution on 
the Chromatographic Peak Profile 
1.Analysis on PE-HPLC 
There was no apparent influence of methanol increase on 
the retention times of analytes at 50 ~L injection volume and 
0.06M buffer concentration. The influence on the peak heights, 
however, was quite pronounced and was different for the two 
analytes (Figure 27). The peak heights for STB increased by 
15.1% as the percentage of methanol increased from 5 to 25%. 
In contrast to STB, peak heights for MBC decreased by 2.8% 
with the methanol increase. For both analytes, peak widths 
were not affected significantly enough to observe any changes 
Table XI* 
Chromatographic Results for STB and MBC when [CH30H] Increased 
from S to 2S% at 0.06M Buffer Concentration 
C~oOH Retention Time (min) Penk Height (cm) STB MBC STB MBC 
S.O 3.S0±.00 4.S6:.1::.02 10.16±.OB B.BS±.09 
1 0.0 3.S6±.02 4.S4±.02 10.0B±.OB B.B6±.12 . 
1 2. S 3.S6±.01 4.S4±.02 10.2S±.OS B.B1±.13 
1 S. 0 3.S6±.02 4.S6±.02 11.23±.03 B.98±.02 
20.0 3.S6±.04 4.S4±.04 11.28±'O3 8.77±.O6 
2 S. 0 3.44±.O2 4.S2:t.04 ·11.69J:.06 8.60±.O4 
*-done on PE·HPLC at SO~tL injection volume 
-....J 
W 
'd'" 
r-... 
4 5 
1 2 3 
MBC 
STB 
FlgurQ 20; Chromatograms of STU (1) and MBC (2) Showing the Effects of Increasing Methanol Concentration in the 
Sample Solvellt, aI50.,L Injoction Volume and O.06M Buffer Concentration. 1) 5% CH30H; 2) 10% CH30H; 
3) 12.5% CH30H; 4) 15% CllaOII; 6)20% CHaOH; 6) 25% CH30H. 
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at increasing methanol concentrations. The above results are 
listed in Table XI. 
2.Analysis on HP-HPLC 
Two factors were different in the basic solution 
composition from the PE study. The buffer concentration was 
changed from 0.06M to 0.007M and the methanol concentration 
range was increased to 5-50% from 5-25%. 
1) At Constant Mass of Analyte Injected 
Retention Time A retention time increases of 0.6, 2.1, 1.1, 
and 0.4% were observed for STB at the injection volumes of 10, 
50, 100, and 200 pL respectively (Table Xlla). The increasing 
trend was less pronounced for the smallest and the largest 
injection volumes as can be seen in Figure 21. For MBC, 
retention times stayed constant as methanol increased from 5 
to 50% for 10 pL injections, and very gradually decreased by 
0.9, 1.3, and 2.4% for 50, 100, and 200 pL injections, 
respectively (Table Xllb and Figure 22). An interesting point 
is that STB retention time increased with an increasing amount 
of methanol in the sample solvent and MBC retention time 
decreased. This resulted in an improved peak resolution. 
Peak Height STB peak heights increased by 2.9, 26.7, and 
15.4% for 10, 50, and 100 uL injections as methanol increased 
from 5 to 50%. For 200 UL injections, peak heights increased 
by 15.1% from 5 to 35% methanol and then decreased by 25.6% 
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for a methanol increase from 35 to 50% (Table XIIa and Figure 
23). It is important to note, that at the lower injection 
volumes the influence of methanol is opposite to that of 
acetonitrile, but that at sufficiently high injection volumes 
(200 ~L) and high methanol content (50%), a decrease in the 
peak height was observed as' were the cases with all the 
acetonitrile experiments. 
MBC peak heights decreased with an increase in the 
methanol concentration. For all four injection volumes, the 
rate of decrease was slower from 5 to 25% methanol and more 
rapid from 35 to 50% as can be observed in Figure 24. The 
decreases of 5.1, 5.5, 15.3, and 30.2% were observed for 10, 
50, 100, and 200 ~L injections (Table XIIb). 
Peak Width A decrease in the STB peak widths was observed as 
the methanol concentration increased. This trend was 
interrupted only for 200 pL injection at 50% methanol as can 
be observed in Figure 25. For MBC, peak widths increased with 
an increase in the methanol concentration. The increases 
became larger at higher injection volumes as shown in Figure 
26. An interesting point is that at 5% methanol in the sample 
solvent, peak widths decreased with an increase in the 
injection volume, while at 50% methanol, peak widths were the 
same for 10 and 50 ~L injections, but increased for the 100 
and 200 ~L injections (Table XIIb). 
Peak Area The peak areas of the two analytes at all four 
injection volumes remained constant as methanol concentration 
in the sample solvent increased as shown in Tables XlIa and 
/I 
TableXlia 
Chromatographic Results for STB when [MeOHl increases from 5 to 50% 
and Injected Mass of Analytes Stays Constant at Increasing Injection Volumes. 
%MeOH RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
TIME (min) (mAUs) (mAU) (min) 
10lll @ 51lg/ml 
5 2.452±.003 83±1 7.08±.01 0.164±.002 O.53±.O1 
5 2.453±.004 83±i 7.04±.O3 O.165±.O02 O.54±.01 
25 2.459±.005 86±3 7.27±.10 0.169±.009 O.56±.01 
25 2.460±.O02 84±1 . 7.23±.06 0.17H 0 0.57±.01 
35 2.46B±.OO2 B4±1 7.15±.OB 0.172±.001 0.56±.01 
50 2.469±.O01 87±1 7.39±.01 O.169±.004 O.58±.O1 
50 2.46B±.OO4 84±4 7.14±.12 O.173±.OO4 0.60±.01 
50 III @ 11lg/ml 
5 2.555±.O01 9B±2 7.31±.01 0.171±.001 O.41±.O1 
5 2.550±.010 9H4 7.20±.13 0.16B±.002 O.39±.Ol 
25 2.608±.010 85±5 7.98±.O6 O.14B±.OO3 1.11±.O1 
25 2.607±.OO3 92±1 7.92±.01 O.153±.O01 1.07±.01 
35 2.592±.001 9H1 8.60±.01 0.145±.002 O.9H.Ol 
35 2.599±.003 92±1 8.56±.02 0.146±.001 0.9H.01 
50 2.S08±.OO2 91±1 9.23±.OB 0.135±.001 0.99±.03 
50 2.605±.007 92±1 9.15±.02 0.136±.001 1.0H.02 
100 III @ .5llg/ml 
5 2.S72±.007 92±1 7.75±.04 0.1S0±.007 0.B6±.03 
5 2.669±.001 92±1 7.72±.01 0.16H.002 0.B8±.03 
25 2.S88±.001 95±3 B.49±.01 0.149±.003 1.13±.03 
25 2.S86±.004 94±1 B.28±.08 O.146±.00B 1.21±.01 
35 2.S86±.001 95±1 8.5H.10 0.147± 0 1.l0±.OS 
35 2.S8S±.004 92±1 8.26±.O1 0.149±.001 1.17±.03 
50 2.S9B±.005 91±1 B.97±.07 0.135± 0 1.29±.02 
50 2.S98± 0 90±1 B.8S±.01 O.132±.O03 1.32±.01 
200lll @ .25llg/ml 
5 2.799±.009 109 ±i 10.SH.OS O.154±.O04 O.S5±.01 
5 2.79S±.OO1 107 ±1 10.76±.01 0.153±.OO3 O.S6±.01 
25 2.79B±.004 114 ±2 11.8B±.03 0.130±.002 0.B2±.01 
25 2.802±.002 112 ±1 11.74±.O9 0.130± 0 0.85±.01 
35 2.798±.004 114 ±2 12.5H.03 O.124±.002 O.B2±.01 
35 2.799±.003 114 ±i 12.3H.06 0.12S±.001 O.83±.Oi 
50 2.811±.001 100 ±2 9.47±.14 0.147± 0 1.14±.03 
50 2.806±.O05 101 ±2 9.00±.63 0.148±.001 1 ~ 11 ±. 01 
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TableXlib 
Chromatographic Results for MBC when [MeOHl in the Sample Solvent increases from 
5 to 50% and Injected Mass of Anatytes Stays Constant at Increasing Injection Volumes. 
%MeOH RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
TIME (min) (mAUs) (mAU) (min) 
10jll @ 5jlg/ml 
5 3.322±.001 108±1 6.39±.04 0.234±.002 0.52 ±.02 
5 3.322±.003 112±2 6.44±.01 0.238±.012 0.51 ±.O1 
25 3.320±.O10 108±5 6.30±.13 0.239±.002 0.53 ±.O1 
25 3.323±.006 108±3 6.24±.02 0.245±.007 0.52 ±.01 
35 3.332±.005 106±2 6.15±.05 0.246±.002 0.53 ±.01 
50 3.322±.007 105±2 6.10±.07 0.236±.006 0.53 ±.01 
50 3.319±.004 109±3 6.08±.04 0.250±.O11 0.52 ±.01 
50 III @ 1jlgiml 
5 3.40H.OO2 114±2 7.38 ±.11 0.215±.007 0.55 ±.O1 
5 3.40H.012 117±5 7.57 ::.09 0.216::.005 0.54 ±.O2 
25 3.359±.003 115±2 7.12 ±.O1 0.226±.006 0.55 ±.01 
25 3.373±.O13 114±3 7.13 ±.04 O.228±.007 0.58 ±.02 
35 3.374±.001 118±1 6.64 ±.07 0.24H.007 0.54 ±-O1 
35 3.37H.008 118±3 6.74 ±.23 0.238±.001 0.57 ±.01 
50 3.370±.O06 118±2 7.07 ±.03 0.235±.002 0.55 ±.01 
50 3.370±.006 116±1 7.06 ±.07 0.234±.002 0.55 ±.02 
100 jll @ .5jlg/ml 
5 3.466±.003 118±3 8.11 ±.06 0.210±.006 0.54 ±.01 
5 3.465±.00i 118±1 8.09 ±.02 0.209±.001 0.55 ±.01 
25 3.447±.003 118±5 7.59 ±.09 0.222± 0 0.59 ±.03 
25 3.45H.003 119±2 7.58 ±.Oi 0.223±.003 0.59 ±.01 
35 3.433±.00i 119±3 7.04 ±.11 0.232±.001 0.60 ±.01 
35 3.430±.004 113±2 7.01 ±.10 0.227±.O10 0.62 ±.01 
50 3.420±.004 118±1 6.86 ±.02 0.244±.005 0.63 ±.03 
50 3.423±.004 118±1 6.87 ±.01 0.241± 0 0.63 ±.02 
200jll @ .25jlg/ml 
5 3.577±.004 141±3 10.66±.02 0.193±.001 0.51 ±.O1 
5 3.573±.003 143±2 i0.60±.06 0.197±.003 0.50 ±.01 
25 3.544±.005 145±1 9.99±.03 0.211±.005 0.60 ±.10 
25 3.549±.002 147±2 9.99±.06 0.211±.004 0.57 ±.01 
35 3.527±.003 145±2 9.07±.02 0.230±.005 0.61 ±.02 
35 3.530±.002 145±3 9.00±.05 0.230±.007 0.61 ±.09 
50 3.490±.002 139±6 7.40± 12 0.275±.005 0.69 ±.02 
50 3.486±.001 145±1 7.44±.03 0.277±.003 0.67 ±.01 
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Figure 21: Plot of Retention Time vs. Methanol Concentration in the Sample Solvent 
for STB at Constant Analyte Mass for 10, 50. 100 and 200 III 
Injections. 
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Figure 22: Plot of Retention Time vs. Methanol Concentration in the Sample Solvent 
for MBC at Constant Analyte Mass for 10, 50,100. and 200 III 
Injections. 
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Figure 23: Plot of Peak Height vs. Methanol Concentration in the Sample Solvent 
for STB at Constant Analyte Mass for 10,50,100, and 200 ~L 
Injections. 
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Fig!Jr~ 24; Plot of Peak Height vs. Methanol Concentration in the Sample Solvent 
for MBC at Constant Analyte Mass for 10,50,100, and 200 ~L 
Injections. 
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Figure 25: Plot of Peak Width vs. Methanol Concentration in the Sample Solvent 
for STB at Constant Analyte Mass for 10,50,100 and 200 III 
Injections . 
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Eigl.m~ 22; Plot of Peak Width vs. Methanol Concentration in the Sample Solvent 
for MBC at Constant Analyte Mass for 10, 50,100, and 200 III 
Injections . 
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Figure 27: Chromatograms 01 STB (1) and MBC (2))or Constant Mass Study Showing the Effects of 
Increasing Methanol Concemration in the Sample Solvent on the Peak Profiles. 1) 5% CH30H; 
2) 25% CH30H; 3) 35% CH30H; 4) 50% CH30H. 
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XIIb. 
Peak Symmetry An increase in the peak symmetry was also 
observed with an increase in the methanol concentration. For 
STB, increases became larger with the increase in the 
injection volume. For MBC, peak symmetry stayed constant for 
the 10 and 50 ~L injection~ and increased for the 100 and 200 
uL injections as shown in Table Xllb. 
2) At Increasing Mass of Analytes Injected 
Retention Time The retention time of STB increased with an 
increase in methanol concentration. The increases of 0.7, 2.6, 
4.5, and 6.3% were observed for 10, 50, 100, and 200 uL 
injections (Tabl~ XIlIa). While for constant mass study, 
increases became smaller at increasing volumes ( Figure 21), 
at increasing mass, retention time increases became larger at 
higher injection volumes as shown in Figure 28. Another 
difference from the constant mass study was the occurence of 
split peaks. The split peaks were observed for the 100 pL 
injection at 25% methanol and for 200 UL injections at 
methanol concentrations of 25, 35, and 50%. 
For MBC, the retention time for a 10 pL injection 
remained constant as methanol concentration increased. For 50, 
100, and 200 ~L injections, retention time decreased by 0.6, 
2.5, and 3.0% with an increase in the methanol concentration 
as can be observed from Figure 29. 
Peak Height A small increase in the STB peak height of 2.3% 
was observed for the 10 ~L injection, and a much larger 
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TatleXllla 
Chromatographic Results for sm when [MeOH] in the Sample Solvent increases from 
5 to 50% and Injected Mass of Analytes Increases with Increasing Injection Volume. 
%MeOH RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
TIME (min) (mAUs) (mAU) (min) 
10lll @ 51lg/ml 
5 2.452±.003 83±1 7.08±.01 0.164±.OO2 0.53±.01 
5 2.453±.004 83±1 7.04±.03 O.165±.OO2 O.54±.O1 
25 2.459±.005 86±3 7.27±.10 0.169±.009 0.56±.01 
25 2.461±.002· 84±1 7.23±.06 0.171±0 0.57±.01 
35 2.468±.002 84±1 7.15±.08 0.172±.001 0.56±.01 
50 2.469±.001 87±i 7.39±.01 0.169±.009 0.58±.O1 
50 2.468±.004 84±4 7.14±.12 0.173±.OO4 O.61±.O1 
50 III @ 51lg/mL 
5 2.553 90 6.59 0.184 0.41 
5 2.554 89 6.48 0.184 0.41 
25 2.611 92 7~81 o ~:::~ • t_o.J 1 ~ 17 
25 2.617 92 7.79 0.155 1.19 
35 2.601 91 7.92 0.158 0.93 
50 2.611 89 8.26 0.146 1.16 
50 2.629 90 8.14 0.146 1.18 
100 III @ 51lg/ml 
5 2.614 89 7.21 0.167 0.32 
5 2.622 89 7.12 0.166 0.32 
25* 2.631 45 5.35 0.134 1.71 
25* 2.742 48 5.98 0.112 0.51 
25* 2.636 46 5.36 0.138 1.74 
25* 2.746 47 5.75 0.113 0.49 
35 2.718 83 6.43 0.201 1.57 
50 2.728 88 6.53 0.182 2.06 
50 2.741 92 6.42 0.185 2.14 
200lll @ 51lg/ml 
5 2.743 90 7.03 0.175 0.34 
5 2.743 88 6.89 0.175 0.35 
25* 2.748 55 4.73 0.167 1.21 
25* 2.813 33 3.63 0.123 0.43 
25* 2.748 62 4.58 0.178 1.33 
25* 2.817 26 3.41 0.124 0.41 
35* 2.823 55 3.58 0.193 1.41 
35* 2.916 38 4.19 0.128 0.65 
50* 2.521 19 2.26 0.125 0.78 
50* 2.914 72 4.14 0.231 2.27 
50* 2.531 18 2.23 0.122 0.83 
50* 2.918 73 4.16 0.233 2.31 
85 
Table Xllib 
Chromatographic Results for MBC when [MeOHl in the Sample Solvent increases from 
5 to 50% and Injected Mass of Analytes Increases with Increasing Injection Volume. 
%MeOH RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
TIME (min) (mAUs) (mAU) (min) 
10lll @ 51lg /mL 
5 3.322±.001 108±1 6.39±.04 0.234±.002 0.52 ± .02 
5 3.322±.003 112±2 6.44±.O1 0.238±.O12 0.51 ± .01 
25 3.320±.O10 108±""5 6.30±.13 0.239±.002 0.53 ± .01 
25 3.323±.006 108±3 6.24±.02 0.245±.007 0.52 ± .01 
35 3.332±.005 106:±:2 6.15±.05 0.246±.002 0.53 ::: .01 
50 3.322±.007 105:±:2 6.10±.07 0.236±.006 0.53 :±: .01 
50 3.319±.004 109:±:3 6.08±.04 0.250±.O11 0.52 ± .01 
50 III @ 51lg/mL 
5 3.382 116 7.17 0.231 0.54 
5 3.384 117 7.18 0.231 0.54 
25 3.381 119 6.96 0.243 0.53 
25 3.379 117 6.93 0.241 0.54 
35 3.361 119 6.62 0.257 0.54 
50 3.362 123 6.78 0.268 0.51 
50 3.362 123 6.76 0.261 0.51 
1 00 III @ 51lg/ml 
5 3.445 116 6.72 0.266 0.59 
5 3.454 113 6.75 0.277 0.56 
25 3.436 123 6.65 0.255 0.64 
25 3.442 125 6.57 0.261 0.64 
35 3.427 125 6.22 0.278 0.64 
50 3.403 125 6.11 0.285 0.65 
50 3.411 126 6.07 0.281 0.67 
200lll @ 51lg/mL 
5 3.617 122 6.31 0.302 0.41 
5 3.616 124 6.31 0.306 0.41 
25 3.556 125 5.33 0.365 0.88 
25 3.552 124 5.13 0.378 0.89 
35 3.554 126 4.86 0.345 1.01 
50 3.503 125 4.49 0.392 0.94 
50 3.511 125 4.91 0.398 0.95 
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Figure 28: Plot of Retention Time VS. Methanol Concentration in the Sample Solvent 
for STS at Increasing Analyte Mass for 10, 50, 100 and 200 III 
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Figure 29: Plot of Retention Time VS. Methanol Concentration in the Sample Solvent 
for MSC at Increasing Analyte Mass for 10,50,100, and 200 III 
Injections. 
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Figure 3Q: Plot of Peak Height vs. Methanol Concentration in the Sample Solvent 
for STB at Increasing Analyte Mass for 10, 50, 100 and 200 J.1L 
Injections. 
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Figure 32: Plot of Peak Width vs. Methanol Concentration in the Sample Solvent 
for STB at Increasing Analyte Mass for 10, 50, 100 and 200 JlL 
Injections . 
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Figure 33: Plot of Peak Width vs. Methanol Concentration in the Sample Solvent 
for MBC at Increasing Analyte Mass for 10, 50,100, and 200 JlL 
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increase of 25.4~ was observed for the 50 pL injection. At 100 
uL, peak height decreased by 9.5~, and at 200 pL injection, 
the decrease was even more pronounced and was accompanied by 
peak splitting. Results are listed in Table XIIIa and are 
graphically shown in Figure 30. 
In the MBC study, peak heights decreased with methanol 
increase from 5 to 50% (Table XIIlb). The decreases of 5.3, 
5.6, 9.5, and 25.5% were observed for 10, 50, 100, and 200 ~L 
injections as shown in Figure 31. These decreases are similar 
to constant mass study for 10, and 50 pL injections, and are 
lower by around 5~ for the 100 and 200 ~L injections. 
Peak Width There was no pronounced influence on the peak 
width of STB at 10 pL injection. For a 50 pL injection, peak 
width decreased with methanol increase, while for 100 and 200 
uL injections, peak widths increased with an increase in the 
methanol concentration as shown in Figure 32. For MBC, an 
increasing trend in the peak width was observed, similar to 
that of constant mass study as shown in Figure 33. 
Peak Area The peak area of STB was not affected by the 
methanol increase in the sample solvent for 10 and 50 pL 
injections, but at 100 and 200 pL injections, split peaks were 
observed. The areas of the two peaks, however, always equaled 
the area observed for the single peak, as can be seen in Table 
Xllla. Peak area was not affected by the increase in the 
methanol concentration for any of the injection volumes 
studied for MBC (Table Xlllb). 
Peak Symmetry For STB, peak symmetry increased at higher 
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methanol concentrations. The increases became larger is the 
injection volume increased (Table Xllla). An increase in the 
peak symmetry for MBC was observed only at 100 and 200 pL 
injections. 
C. Effect of the pH of the Sample Solution on the 
Chromatographic Peak Profile 
1.Analysis on PE-HPLC 
For this study the pH of the sample solutions was varied 
from 4.42 to 9.10. The injection volume for the analysis was 
50 ~L. The complete results are listed in Table XIV. 
Retention Time A significant decrease in the STB retention 
time of 21.1% was observed as pH of the solution increased 
from 4.42 to 9.10 (Table IVX). At the 
pH of 4.42 the retention time of STB became so close to that 
of MBC that there was no resolution between the two peaks. The 
retention time of MBC was not affected by an increase in the 
pH of the sample solution. 
Peak Height An increase in the pH of the sample solution 
resulted in the peak height increase of 80.9% for STB. For MBC 
however, peak height was not affected, except at pH 9.10, 
where a small decrease was observed (Table XIV). 
Table XIV* 
Influence of pH in the Sample Solvent on the Penk Profile in RP-HPLG 
pH of Buffer RETENTION TIME RETENTION TIME 
(min) for STB (min) for MBG 
4.42 4.03±.02 4.03±.02 
S.9S 3.78±.03 4.03±.02 
6.S0 3.38±.03 4.04:t.04 
6.74 3.32±.03 4.0S±.01 
7.40 3.26±.O2 4.0S±.01 
7.90 3.21 ±.OO 4.0S±.OO 
9.10 3.18±.00 4.04±.01 
*-analysed on PE-HPLG at SO JlL injection volume 
**-no separation of two compounds 
PEAK HEIGHT PEAK HEIGHT 
(ern) for STB (cm) for MBG 
" " " .* 
5.4l±.03 12.0S±.OS 
7.72±.Ol i0.SS±.OS 
8.35±.OS '10.46±.OS 
9.00±.OO 10.43±.O3 
9.50±.00 10.S8±.06 
9.90±.20 9.97±.10 
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2.Analysis on HP-HPLC 
In this study pH was varied from 5 to 8. This range was 
chosen since buffering capacity of the phosphate buffer at 
higher and lower pH was poor and had deteriorating effects on 
the reversed phase column. The concentration of buffer 
differed from the PE study and was equal to that of the mobile 
phase of O.007M. 
1) At Constant Mass of Analyte Injected 
The complete results are listed in Table XVa STB and 
Table XVb for MBC. 
Retention Time STB retention time was not influenced by the 
pH change at 10 and 50 pL injections. As the injection volume 
increased a successively larger decreases in the retention 
time of 1.3, and 6.5% were observed for 100, and 200 pL 
injections as shown in Figure 35. For MBC, pH had no influence 
on the retention time at any injection volumes (Figure 36). 
Peak Height For 10 pL injection, peak height of STB was not 
influenced by the increase in pH. For higher injection volumes 
peak heights increased as the pH of sample solution increased 
from 5 to 8. Increases of 10.7, 37.3, and 25.7% were observed 
for 50, 100, and 200 pL injections (Figure 37). Peak height 
for MBC was not affected by the change in the pH (Figure 38). 
Peak Yidth A gradual decrease in the STB peak width was 
observed as pH was increased (Figure 39). In this study there 
was marked increase in the peak widths with the increase in 
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TableXVa 
Chromatographic Results for STB when pH of the Sample Solution increases from 
5 to 8 and Injected Mass of Analytes Stays Constant with Increasing Injection Volume. 
pH OF pH OF RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
BUFFER SOLUTION TIME (min) (mAUs) (mAU) (min) 
1 Olll @ 5JlgIrrL 
5.00 5.61 2.490±.020 87±2 8.87±.25 0.137±.002 0.43±.O1 
5.00 5.58 2.502±.005 87±2 8.98±.15 0.135±.004 0.43±.O1 
6.00 6.33 2.494±.008 85±1 8.86±.25 0.134±.004 O.42±.O1 
6.00 6.37 2.504±.004 87±2 8.90±.24 0.136±.001 0.42±.O1 
7.00 7.37 2.500±.003 84±1 8.44±.18 0.137±.006 0.44±.02 
7.00 7.38 2.498±.003 8H1 8.47±.16 0.135±.003 0.43±.03 
8.00 8.27 2.499±.006 85±1 9.0H.15 0.132±.001 0.44±.01 
8.00 8.17 2.500±.005 86±1 8.98±.14 0.134±.003 0.43±.O1 
50 j.1l @ 11lQ'fTi.. 
:: no 
....... -"*' '1;0> 5.44 2.635:::.007 91±1 8.9H.15 0.155±.002 0.66±.O3 
5.00 5.55 2.629±.O16 90±2 8.8H.23 0.155±.003 0.6H.04 
6.00 6.31 2.634±.003 89±1 9.0H.06 0.146±.008 0.6H.03 
6.00 6.36 2.628±.009 89±1 9.011.11 0.150±.OO1 0.62±.04 
7.00 7.2.7 2.630±.009 93±1 9.5H.18 0.148±.002 0.63±.04 
7.00 7.36 2.627±.002 90±1 9.50±.15 0.144±.004 0.62±.05 
8.00 8.17 2.622±.002 9H1 9.77±.18 0.141±.003 0.6H.05 
8.00 8.11 2.627±.O11 92±2 9.86±.17 0.14H.001 0.64±.04 
100 III @ .51l9'mL 
5.00 5.59 2.762 93 7.19 0.178 0.92 
5.00 5.59 2.763 94 7.21 0.174 0.91 
6.00 6.35 2.757 92 7.36 0.164 0.84 
6.00 6.35 2.756 92 7.35 0.167 0.96 
7.00 7.37 2.735 90 8.37 0.146 0.98 
7.00 7.37 2.724 91 8.24 0.151 0.95 
8.00 8.22 2.717 94 9.87 0.131 0.88 
8.00 8.22 2.739 91 9.91 0.126 0.86 
200JJl @ .25j.Jg.tli 
5.00 5.59 2.956 106 7.11 0.201 0.36 
5.00 5.59 2.961 105 6.81 0.208 0.33 
6.00 6.35 2.908 107 7.09 0.201 0.31 
6.00 6.35 2.904 109 7.02 0.204 0.31 
7.00 7.37 2.781 107 8.23 0.171 0.25 
7.00 7.37 2.785 109 8.33 0.171 0.24 
8.00 8.22 2.772* 47 8.81 0.081 0.92 
8.00 8.22 2.851* 60 8.49 0.109 0.21 
8.00 8.22 2.768 109 8.74 0.164 0.25 
'* denotes split peaks 
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TableXVb 
Chromatographic Results for MBC when pH of the Sample Solution increases from 
5 to 8 and Injected Mass of Analytes Stays Constant with Increasing Injection Volume. 
pH OF pH OF RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
BUFFER SOLUTION TIME (min) (mAUs) (mAU) (min) 
1 0J.ll @ ~rrL 
5.00 5.61 3.435±.023 110±1 7.65±.30 0.207±.006 0.45±.O1 
5.00 5.58 3.446±.O17 113±3 7.72±.14 0.207±.008 0.44±.01 
6.00 6.33 3.44H.019 11H1 7.64±.25 0.207±.008 0.45±.01 
6.00 6.37 3.449±.009 112±2 7.68±.25 O.21H.007 0.46±.O1 
7.00 7.37 3.448±.O14 114±1 7.64±.17 0.213±.004 0.44±.O1 
7.00 7.38 3.448±.O17 112±1 7.66±.19 0.212±.009 0.45±.O1 
8.00 8.27 3.448±.019 106±5 7.47±.13 0.203±.O10 0.47±.03 
8.00 8.17 3.453±.020 109±3 7.54±.16 0.212±.008 0.45±-01 
50 J.ll@ 1 J.Otni.. 
5.00 5.44 3.522=.015 117±1 8.83::t.17 0.19:5±.004 0.46±.02 
5.00 5.55 3.516±.027 117±3 B.8H.12 0.192±.007 0.46±.O1 
6.00 6.31 3.524±.012 116±1 8.75±.22 O.i9H.OO6 0.45±.01 
S.OO 6.36 3.517±.O18 115±3 8.75±-23 0.193±.002 0.45±.01 
7.00 7.27 3.522±.020 119±1 8.86±.27 0.190±.001 0.45±.02 
7.00 7.36 3.524±.019 116±1 8.80±.28 0.189±.001 0.45±.01 
8.00 8.17 3.518±.O14 115±2 8.76±.28 0.188±.003 0.46±.01 
8.00 8.11 3.523±.003 118±1 8.82±.25 0.191±.001 0.45±.01 
100 J.ll @ .5~rnL 
5.00 5.59 3.594 119 9.03 0.193 0.53 
5.00 5.59 3.593 119 8.94 0.191 0.52 
6.00 6.35 3.598 118 8.91 0.191 0.52 
6.00 6.35 3.595 115 8.91 0.186 0.53 
7.00 7.37 3.595 115 8.89 0.191 0.51 
7.00 7.37 3.595 111 8.81 0.192 0.55 
8.00 8.22 3.591 115 8.95 0.185 0.52 
8.00 8.22 3.615 116 8.98 0.183 0.51 
200J.1l..@~ 
5.00 5.59 3.699 142 9.99 0.215 0.58 
5.00 5.59 3.713 149 9.92 0.215 0.65 
6.00 6.35 3.709 144 9.86 0.223 0.63 
6.00 6.35 3.711 146 9.96 0.223 0.63 
7.00 7.37 3.693 139 9.99 0.211 0.64 
7.00 7.37 3.699 142 9.95 0.217 0.62 
8.00 8.22 3.707 140 9.89 0.213 0.63 
8.00 8.22 3.702 141 9.92 0.221 0.62 
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Figure 35: Plot of Retention Time vs. pH of the Sample Solution for STB 
at Constant Analyte Mass for 10,50,100 and 200 III 
Injections. 
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Figure 36: Plot of Retention Time vs. pH of the Sample Solution for MBC 
at Constant Analyte Mass for 10, 50, 100, and 200 III 
Injections. 
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Figure 37: Plot of Peak Height vs. pH of the Sample Solution for STB 
at Constant Analyte Mass for 10, 50, 100 and 200 ~L 
Injections. 
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Figure 38: Plot of Peak Height vs.pH of the Sample Solution for MBC 
at Constant Analyte Mass for 10, 50, 100, and 200 ~L 
Injections. 
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Figure 39: Plot of Peak Width vs. pH of the Sample Solution for STB 
at Constant Analyte Mass for 10. 50.100 and 200 /-lL 
Injections . 
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Figure 40: Plot of Peak Width vs. pH of the Sample Solution for MBC 
at Constant Analyte Mass for 10. 50. 100. and 200 /-lL 
Injections. 
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the injection volume as can be seen in Figure 39. At pH 5, 
peak widths were 0.137, 0.155, 0.178, and 0.201 minutes for 
10, 50, 100, and 200 ~L injections. For MBC, pH had no affect 
on the peak widths. Also, for all four injection volumes peak 
widths for MBC were very similar as shown in Figure 40. 
Peak Area The change in the pH had no affect on the peak 
areas of both analytes as can be observed from Tables XV and 
XVI. 
Peak Symmetry The pH influence on the peak symmetry was 
observed only for STB and only at pH 8 for 100 and 200 ~L 
injections (Table XV). 
2) At Increasing Mass of Analyte Injected 
The complete results are listed in Tables XVIa and XVlb 
and the chromatograms are shown in Figure 41. 
Retention Time Retention time of STB was not influenced at 10 
and 50 pL injections. At 100 and 200 ~L injections, decreases 
of 1.2 and 6.6% were observed. The trend is similar to that in 
the study at constant mass, but is much smaller than for PE 
study. Once again the increase in the pH of the sample 
solution had no influence on the retention time of MBC. 
Peak Height At 10 ~L injection, pH had no pronounced effect 
on the peak height of STB. For 50, 100, and 200 ~L injections, 
however, peak heights increased by 11.9, 25.1, and 71.7% 
(Figure 44). For MBC, the peak heights were not affected by 
the increase in the pH at any of the four injection volumes 
(Figur 45). 
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TableXVla 
Chromatographic Results for STB when pH of the Sample Solution increases from 
5 to 8 and Injected Mass of Analytes Increases with Increasing Injection Volume. 
pH OF pHOF RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
BUFFER SOLUTION TIME (min) (mAUs) (mAU) (min) 
10lll @ 51lg /ml 
5.00 5.61 2.499±.OO2 87±2 8.8H.25 O.137±.OO2 0.43±.O1 
5.00 5.58 2.502±.OO5 87±2 8.98±.15 0.135±.004 0.43±.01 
6.00 6.33 2.494±.008 85±1 8.86±.25 0.134±.004 0.42±.01 
6.00 6.37 2.504±.OO4 87±2 8.90±.24 0.136±.OO1 0.42±.O1 
7.00 7.37 2.500±.OO3 84±1 8.44±.18 0.137±.006 0.44±.02 
7.00 7.38 2.498±.003 8H1 8.47±.16 0.135±.OO3 O.43±.O3 
8.00 8.27 2.499±.006 85±1 9.0H.15 0.132::.001 0.44±.01 
8.00 8.17 2.500±.005 86±1 8.98±.14 0.134±.003 0.43±.O1 
50 III @ 5il9/ml 
5.00 5.61 2.632 93 9.16 0.153 0.59 
5.00 5.58 2.637 93 9.14 0.152 0.59 
6.00 6.33 2.638 92 9.23 0.151 0.59 
6.00 6.37 2.638 92 9.11 0.151 0.61 
7.00 7.37 2.638 86 9.19 0.141 0.62 
7.00 7.38 2.639 86 9.22 0.141 0.65 
8.00 8.27 2.644 91 10.25 0.136 0.66 
8.00 8.17 2.633 91 10.23 0.135 0.64 
100 III @ 51lg/ml 
5.00 5.61 2.744 93 9.63 0.141 0.52 
5.00 5.58 2.748 93 9.68 0.138 0.52 
6.00 6.33 2.742 92 9.89 0.134 0.51 
6.00 6.37 2.749 92 9.91 0.133 0.52 
7.00 7.37 2.728 86 10.59 0.116 0.52 
7.00 7.38 2.736 88 10.69 0.117 0.51 
8.00 8.27 2.714 93 12.09 0.109 0.54 
8.00 8.17 2.711 92 12.05 0.109 0.53 
200 III @ 51lg/ml 
5.00 5.61 3.054 92 7.30 0.194 0.74 
5.00 5.58 3.062 92 7.20 0.186 0.74 
6.00 6.33 3.005 91 7.80 0.167 0.71 
6.00 6.37 2.998 92 7.80 0.169 0.71 
7.00 7.37 2.879 87 10.40 0.118 0.55 
7.00 7.38 2.871 86 10.50 0.119 0.56 
8.00 8.27 2.854 93 12.50 0.106 0.39 
8.00 8.17 2.854 93 12.40 0.107 0.56 
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TableXVlb 
Chromatographic Results for MBC when pH of the Sample Solution increases from 
5 to 8 and Injected Mass of Analytes Increases with Increasing Injection Volume. 
pH OF pHOF RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
BUFFER SOLUTION TIME (min) (mAUs) (mAU) (min) 
10fJ.l @ 51lg/ml 
5.00 5.61 3.435±.023 110±1 7.65±.30 0.207±.006 0.45±.01 
5.00 5.58 3.446±.017 113±3 7.72±.14 0.207±.008 0.44±.01 
6.00 6.33 3,441±.O19 111±1 7.64±.25 O.207±.008 C.45±.01 
6.00 6.37 3,449±.OO9 112±2 7.68±.25 O.211±.007 O.46±.O1 
7.00 7.37 3.448±.O14 114±1 7.64±.17 0.213±.OO4 O.44±.01 
7.00 7.38 3.448±.017 112±1 7.66±.19 O.212±.OO9 O.4S±.01 
8.00 8.27 3,448±.O19 106±5 7.47±.13 0.203±.O10 O.47±.O3 
8.00 8.17 3.453±.O20 109±3 7.54±.16 0.212±.008 O.45±.01 
50 JlL @ 51lg/mL 
5.00 5.61 3.532 119 8.47 0.205 0.41 
5.00 5.58 3.518 120 8.44 0.206 0.39 
6.00 6.33 3.524 123 8.49 0.209 0.38 
6.00 6.37 " ~19 v_-:> 122 8.46 0.209 0.38 
7.00 7.37 3.521 119 8.42 0.206 0.39 
7.00 7.38 3.527 111 8.38 0.205 0.41 
8.00 8.27 3.532 116 8.32 0.202 0.41 
8.00 8.17 3.523 116 8.28 0.207 0.41 
100 III @ 51lg/ml 
5.00 5.61 3.583 125 8.83 0.205 0.39 
5.00 5.58 3.584 124 8.83 0.202 0.37 
6.00 6.33 3.586 124 8.82 0.202 0.51 
6.00 6.37 3.595 121 8.77 0.201 0.39 
7.00 7.37 3.594 119 8.73 0.198 0.39 
7.00 7.38 3.603 124 8.78 0.203 0.39 
8.00 8.27 3.585 118 8.64 0.197 0.41 
8.00 8.17 3.582 117 8.64 0.197 0.41 
200 JlL @ 51lg/ml 
5.00 5.61 3.707 124 9.20 0.194 0.41 
5.00 5.58 3.704 124 9.20 0.194 0.41 
6.00 6.33 3.703 123 9.10 0.194 0.41 
6.00 6.37 3.696 123 9.20 0.194 0.41 
7.00 7.37 3.706 124 9.10 0.195 0.39 
7.00 7.38 3.698 124 9.20 0.195 0.39 
8.00 8.27 3.698 121 9.10 0.193 0.39 
8.00 8.17 3.699 121 9.10 0.194 0.39 
lUZ 
Figure 41; Chromatograms of STB (1) and MBC (2) tor Increasing Mass Study Showing the Effects of 
the Sample Solvent pH at increasing injection Volumes. 1) pH 5.0; 2) pH 6.0; 3) pH 7.0; 4) 
pH 8.0. 
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Plot of Retention Time vs. pH of the Sample Solution for STB 
at Increasing Analyte Mass for 10, 50, 100 and 200 III 
Injections. 
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Figure 43: Plot of Retention Time vs. pH of the Sample Solution for MBC 
at Increasing Analyte Mass for 10, 50,100, and 200 III 
Injections. 
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Figure 44: Plot of Peak Height vs. pH of the Sample Solution for STB 
at Increasing Analyte Mass for 10, 50, 100 and 200 III 
Injections. 
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Figure 46: Plot of Peak Width vs. pH of the Sample Solution for STB 
at Increasing Analyte Mass for 10, 50, 100 and 200 ~ 
Injections . 
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Figure 47: Plot of Peak Width vs. pH of the Sample Solution for MBC 
at Increasing Analyte Mass for 10,50,100, and 200 ~ 
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Peak Width As for constant mass study, here also peak widths 
of STB decreased with the pH increase. The decreases became 
larger as the volume of the injection increased. Decreases of 
2.2, 11.1, 21.5, and 43.9% were observed (Figure 46). It was 
clear that pH had no pronounced effect on the MBC peak width 
(Figure 47). 
Peak Area The peak areas of both analytes were not influenced 
by the increase in the pH of the sample solutions (Tables XVIa 
and XVIb). 
Peak Symmetry The symmetry of both peaks was also not 
affected by the pH increase. 
D. Effect of Buffer Concentration in the Sample Solution on 
the Chromatographic Peak Profile 
1. Analysis on PE-HPLC 
In this experiment buffer concentration was varied from 
o to 0.14 M and the acetonitrile concentration was set to 35%. 
Results were obtained at 10 and 50 ~L injection volumes. The 
complete results are listed in Table XVII. 
Retention Time Buffer concentration had no apparent effect on 
the retention time of STB at 10 ~L injection. At 50 ~L 
injection, a decrease of 5.8% was observed but only for 
highest buffer concentration. For MBC, a minor reduction of 
2.2% was observed at the highest concentration of buffer with 
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Table XVII* 
Influence of Buffer Concentration on the Peak Profile of STB and MBC 
[Buffer] Retention Time (min) Peak Height (cm) 
M STB MBC STB MBC 
10 j.iL 
0.0000 3.18±.02 3.92±.02 11.71±.11 16.42±.10 
0.0007 3.24::.00 3.92±.00 11.99±.16 16.43:::.25 
0.0070 3.20±.00 3.90±.00 12.40±.00 16.61±.20 
0.0700 3.20±.O1 3.92±.02 12.99±.13 16.69±.09 
0.1400 3.20±.01 3.90±.01 13.10±.17 16~ 72±~ 18 
50 j.iL 
0.0000 2.98±.00 3.74±.03 7.65±.09 11.74±.21 
0.0000 3.00±.00 3.70±.00 7.70±.00 11.62±.42 
0.0007 2.98±.01 3.72±.02 8.13±.05 12.07±.03 
0.0007 2.98±.01 3.70±.02 7.92±.10 11.84±.19 
0.0070 3.00±.00 3.68±.02 9.12±.03 12.17±.03 
0.0070 3.00±.00 3.68±.02 8.98±.03 12.02±.08 
0.0700 3.00±.00 3.70±.03 9.49±.34 11.82±.11 
0.0700 2.98±.01 3.66±.02 9.54±.23 11.68±.31 
0.1400 2.80±.00 3.64±.00 10.79±.14 11.83±.17 
0.1400 2.84±.00 3.64±.00 10.75±.15 11.77±.12 
* -analysed on PE-HPLC 
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the 50 uL injection. 
Peak Height An increase in the peak heights was observed with 
buffer concentration increase. For 10 pL injection, peak 
height increased by 11.9% and at 50 ~l injection, increase was 
40.7%. There was no influence on the MBC peak heights. 
2. Analysis on HP-HPLC 
In this study buffer concentration was varied from 0 to 
0.12 M and acetonitrile concentration was set at 5%. 
1) At Constant Mass of Analyte Injected 
The complete results are listed in Table XVIIIa for STB 
and Table XVllIb for MBC. To eliminate any possibility of a 
systematic influence due to the instrument, an injection 
sequence was set up with one injection for each buffer 
concentration at each volume studied. The complete sequence 
was repeated three times. Since the average values were 
obtained with the values of 3 injections which were not made 
consecutively, but were made at different times, a larger 
injection errors were obtained, but the observed trends were 
reproducible. It should be pointed out that the 
reproducibility of MBC measurements in the same analyses was 
much better than for STB as can be observed from Tables XVIIla 
and XVIIlb. 
Retention Time Increases in STB retention times of 2.5, 
2.3, and 1.4% were observed as buffer concentration increased 
109 
TableXVllla 
Chromatographic Results for STB when [Buffer] in the Sample Solvent increases from 
o to 0.12M and Injected Mass of Analytes Stays Constant at Increasing Injection Volume. 
[BUFFER] RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
M TIME (min) (mAUs) (mAU) (min) 
10Jll @ 5Jlg/ml 
0.00 2.248±.O17 80±1 9.35±.14 0.12H.001 0.37±.O1 
0.00 2.250±.004 84±6 9.57±.14 0.122±.006 0.35±.02 
0.0007 2.254±.002 82±1 9.S0±.03 0.118±.002 0.36±.02 
0.0007 2.254±.003 82±4 9.18±.06 0.123±.004 0.35±.O1 
0.007 2.260±.004 85±1 10.13±.13 0.117±.001 0.34±.02 
0.007 2.263±.001 86±2 10.08±.02 0.118±.003 0.36±.O1 
0.07 2.293±.007 89±2 11.1S±.25 0.112±.001 0.35±.02 
0.07 2.288±.004 84±1 11.07±.29 0.112±.003 0.37±.02 
0.12 2.306±.003 89±4 11.30±.33 0.110± 0 0.37±.02 
0.12 2.306±.005 88±1 11.34±.17 0.109±.002 0.37±.02 
50 Jll @ 1 Jlg/ml 
0.00 2.345±.006 92±S 12.7H.SS 0.10H.001 0.37±.02 
0.00 2.343±.001 88±4 12.27±.20 0.100±.005 0.36±.O1 
0.0007 2.339±.001 9H5 12.5H.26 0.10H.005 0.37±.02 
0.0007 2.34H.004 9H2 12.49±.51 0.10H.006 0.36±.03 
0.007 2.352±.002 94±2 12.37±.56 0.104±.003 0.37±.03 
0.007 2.349± 0 92±3 12.19±.60 0.104±.002 0.34±.O1 
0.07 2.385±.001 9H1 11.84±.30 0.105±.002 0.34±.O1 
0.07 2.388±.003 92±2 11.8S±.10 0.107±.003 0.34±.03 
0.12 2.399±.004 92±1 11.9S±.36 0.106±.002 0.34±.02 
0.12 2.396±.003 9H1 11.83±.30 0.10S±.002 0.3S±.02 
100JlI @ .SJlg/ml 
0.00 2.426±.001 93±4 12.1H.33 0.10S±.007 0.39±.O1 
0.00 2.427± 0 97±4 12.04±.24 0.110±.00S 0.38±.02 
0.0007 2.427±.001 97±1 12.00±.47 0.11H.002 0.36±.03 
0.0007 2.430±.00S 96±1 12.03±.40 0.110±.00S 0.37±.O1 
0.007 2.434±.001 93±4 11.70±.30 0.109±.007 0.38±.O1 
0.007 2.435±.003 94±1 11.69±.40 0.111±.004 0.37±.O1 
0.07 2.465±.001 101±4 11.69±.34 0.117±.009 0.34±.O1 
0.07 2.456±.008 98±6 11.46±.13 0.117±.008 0.34±.O1 
0.12 2.462±.001 96±1 12.00±.46 0.109±.004 0.36±.O1 
0.12 2.461±.005 94±2 11.50±.57 0.175±.006 0.35±.O1 
200Jll @ .25Jlg/ml 
0.00 2.557±.001 112±2 12.86± .83 0.120±.O10 0.40±.O1 
0.00 2.556±.001 112±; 12.68±1.09 0.123±.O13 0.42±.05 
0.0007 2.556±.008 109±3 12.33±1.10 0.125±.O10 0.37±.03 
0.0007 2.559±.008 112±1 12.29±1.44 0.129±.029 0.39±.02 
0.007 2.563±.002 11H1 11.92±1 .10 0.13H.016 0.38±.O1 
0.007 5.565±.003 110±3 11.94±1.26 0.129±.O13 0.37±.O1 
0.07 2.559±.009 115±2 12.62±1.S0 0.126±.O19 0.33±.02 
0.07 2.557±.005 116±2 12.S8±1.40 0.127±.O16 0.32±.02 
0.12 2.537±.005 120±7 12.46±1.40 0.134±.021 0.33±.06 
0.1 2 2.450±.008 107±1 11.20±1.00 0.132±.020 0.32±.06 
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TableXVlllb 
Chromatographic Results for MBC when [Buffer] in the Sample Solvent increases from 
o to 0.12M and Injected Mass of Analytes Stays Constant at Increasing Injection Volume. 
[BUFFER] RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
M TIME (min) (mAUs) (mAU) (min) 
10fll @ Sflg/mL 
0.00 3.310±.020 109±1 7.82±.17 0.203±.004 0.38±.02 
0.00 3.320±.020 109±2 7.8S±.14 0.198±.001 0.39±.02 
0.0007 3.314± 0 111±1 8.0H.01 0.198±.003 0.39±.02 
0.0007 3.31S±.001 113±2 8.02±.09 0.200±.001 0.40±.01 
0.007 3.322±.004 112±2 7.87±.07 0.20S±.008 0.39±.01 
0.007 3.323±.002 110±1 7.83±.08 0.20S±.002 0.39±.01 
0.07 3.323±.001 11H1 7.89±.04 0.204±.006 0.39±.01 
0.07 3.318±.001 112±3 7.84±.08 0.210±.002 0.38±.01 
0.12 3.320±.002 112±2 7.8S±.OS 0.206±.004 0.39±.01 
0.12 3.322±.003 111±3 7.88±.17 0.20S±.006 0.38±.02 
SO III @ 1 Ilg/ml 
0.00 3.42S± 0 119±0 8.93±.10 0.192±.008 0.37±.02 
0.00 3.421±.00S 117±1 8.8H.01 0.183±.002 0.37±.01 
0.0007 3.419±.003 118±1 8.87±.04 0.190±.003 0.36±.01 
0.0007 3.422±.002 118±1 8.8H.OS 0.188±.001 0.36±.01 
0.007 3.426±.002 117±2 8.80±.03 0.189± 0 0.36±.01 
0.007 3.417±.007 117±2 8.79±.OS 0.19H.004 0.36±.02 
0.07 3.419±.003 120±2 8.89±.02 0.188±.003 0.36±.01 
0.07 3.420±.001 117±1 8.87±.02 0.191±.004 0.38±.01 
0.12 3.412±.001 118±1 8.96±.01 0.184±.001 0.37±.01 
0.12 3.40S±.007 116±3 8.98±.01 0.186±.005 0.37±.03 
100lll @ .Sllg/mL 
0.00 3.490±.007 119±2 8.99±.01 0.188±.001 0.37±.01 
0.00 3.492±.007 117±2 8.90±.06 0.188±.001 0.37±.02 
0.0007 3.491±.003 117±1 8.82±.12 0.190± 0 0.37±.01 
0.0007 3.494±.010 118±1 8.89±.08 0.193±.002 0.36±.01 
0.007 3.490±.009 119±1 8.87±.OS 0.192±.007 0.36±.01 
0.007 3.493±.004 117±7 8.85±.06 0.197±.004 0.36±.03 
0.07 3.480±.005 120±2 9.04±.01 0.192±.004 0.36±.01 
0.07 3.473±.OO3 122±3 9.1H.01 0.19S±.004 0.36±.01 
0.12 3.4S9±.003 11S±1 9.1S±.13 0.186±.004 0.36±.01 
0.12 3.4S9±.002 109±2 8.9H.1S 0.17S±.006 0.39±.02 
200fll @ .2Sllg/mL 
0.00 3.602±.010 143±1 10.68±.1S 0.196±.002 0.3S±.01 
0.00 3.S98±.009 143±2 10.S1±.17 0.196±.009 0.3S±.01 
0.0007 3.602±.00S 139±3 10.34±.24 O.195±.004 0.36±.01 
0.0007 3.605±.01S 140±1 10.27±.29 0.199±.012 0.36±.01 
0.007 3.600±.006 144±1 10.46±.28 0.196±.009 0.35±.01 
0.007 3.60S±.008 142±2 10.40±.36 0.196±.003 0.35±.01 
0.07 3.583±.009 144±1 10.61±.38 0.194±.006 0.35±.01 
0.07 3.S8H.009 141±2 10.62±.33 O.196±.006 0.35±.O1 
0.12 3.S63±.002 143±5 10.78±.29 0.194±.010 0.39±.04 
0.12 3.S63±.009 132±1 9.93±.44 0.195±.010 0.35±.01 
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Figure 48: Chromatograms of STB (1) and MBC (2) for Constant Mass Study Showing the Effects of 
Increasing Buffer Concentration in the Sample Solvent: 1) O.OM; 2) O.0007M; 3) O.007M; 
4) O.07M; 5) O.12M. 
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Figyri 4~: Plot of Retention lime vs. log [Buffer Concentration] for STB 
at Constant Analyte Mass for 10, 50,100 and 200 J.ll 
Injections. 
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Figyri 50: Plot of Retention Time vs. 10gIBuffer Concentration] for MBC 
at Constant Analyte Mass for 10, 50, 100, and 200 J.ll 
Injections. 
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Figure 51: Plot of Peak Height vs. 10g[Buffer Concentration] for STB 
at Constant Analyte Mass for 10, 50,100 and 200 ~L 
Injections. 
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Figure 52: Plot of Peak Height vs. 10g[Buffer Concentration] for MBC 
at Constant Analyte Mass for 10,50,100, and 200 ~L 
Injections. 
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Flgyre 53: Plot of Peak Width vs. Iog[Buffer Concentration] for STB 
at Constant Analyte Mass for 10, 50, 100 and 200 IJ.L 
Injections. 
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Figure 54: Plot of Peak Width vs. 10g[Buffer Concentration] for MBC 
at Constant Analyte Mass for 10, 50,100, and 200 J.1.l. 
Injections. 
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for 10, 50, and 100 pL injections. The increases became 
smaller as the injection volume became larger. For 200 pL 
injection there was no observable effect (Table XVllla and 
Figure 49). This trend was very similar to the methanol study 
at constant mass. The decreasing influence of buffer 
concentration on the retention time of MBC was observed only 
at 0.12 M concentration for 50 pL injection, and for 0.07 and 
0.12 M concentrations at 100 and 200 pL injections (Table 
XVlllb and Figure 50). 
Peak Height An increase in the STB peak height of 19.7% was 
observed only for 10 pL injections, wher~ analyte 
concentrations were 5 ~g/mL. For 50 and 100 pL injections, 
where analyte concentrations were 5 and 10 times lower, a very 
gradual decrease in the peak height was observed. For 200 ~L 
injection, where analyte concentrations were 20 times smaller 
no obvious trend was observed (Figure 51). The buffer 
concentration had no significant effect on the peak heights of 
MBC at any of the four volumes studied, as shown in Figure 52. 
Peak Width Peak widths for STB decreased at 10 pL injection 
and showed no pronounced change 50, 100, and 200 pL 
injections (Figure 53). Peak widths of MBC were not influenced 
at any volume by the increase in the buffer strenght (Figure 
54). For both analytes somewhat irregular behavior was 
observed for the highest buffer concentration of 0.12M. 
Peak Area The peak area of STB was not greatly influenced by 
the buffer concentration (Table XVllla). A small reduction in 
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the peak area of STB was observed only at 5 pg/mL for 10 pL 
injection when no buffer was present in the sample solution, 
or at very low buffer concentration of 0.0007 M. For MBC the 
only effect was a loss of reproducibility at highest buffer 
concentration and highest injection volume. 
Symmetry For 10 pL injection, symmetry was constant for STB. 
For 50, 100, and 200 uL injections, a small increase in the 
symmetry was observed. Peak symmetry of MBC did not change. 
2) At Increasing Mass .. of Analyte Injected 
The complete results are listed in Tables XIX. and XIXb 
and the sample chromatograms are shown in Figure 55. 
Retention ~ime An increase in the STB retention time of 2.5 
and 3.0% were observed for 10 and 50 pL injection volumes. The 
only other change was a decrease in retention time for buffer 
concentration increase from 0.07 to 0.12M at 200 uL injection 
as shown in Figure 56. For MBC, the only influence was a small 
decrease at 100 and 200 UL injections of 1.3 and 1.0% as 
observed in Figure 57. 
Peak Height STB peak heights increased at higher buffer 
concentrations as shown in Figure 58. The increases were 19.7, 
9.5, 18.9 and 8.2% for 10, 50, 100, and 200 pL injections 
respectively. An interesting factor here was the variation in 
the increases at different injection volumes. This will be 
discussed in section IV. Peak height of MBC was not affected 
except for a small increase at the highest buffer 
concentration as shown in Figure 59. This was also the case in 
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Table XIXa 
Chromatographic Results for STB when [Buffer] in the Sample Solvent increases from 
o to 0.12M and Injected Mass of Analytes Increases with Increasing Injection Volume. 
[BUFFER] RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
M TIME (min) (mAUs) (mAU) (min) 
10ill @ 5il9/ml 
0.00 2.247±.009 80 ± 1 9.35 ±.14 0.121±.001 0.37 ±.01 
0.00 2.250±.004 84 ±6 9.57 ±.14 0.122±.006 0.35 ±.02 
0.0007 2.254±.002 82 ± 1 9.50 ±.03 0.118±.002 0.36 ±.02 
0.0007 2.254±.003 82 ±4 9.18 ±.06 0.123±.004 0.35 ±.01 
0.007 2.260±.004 85 ± 1 10.13 ±.13 0.117±.001 0.34 ±.02 
0.007 2.263±.001 86 ±2 10.08 ±.02 0.118±.003 0.36 ±.01 
0.07 2.293±.002 89 ±2 11.15 ±.25 0.112±.001 0.35 ±.02 
0.07 2.288±.004 84 ± 1 11.07 ±.29 0.112±.003 0.37 ±.02 
0.12 2.306±.003 89 ±4 11.30 ±.33 0.110± 0 0.37 ±.02 
0.12 2.306±.005 88 ±1 11.34 ±.17 0.109±.002 0.37 ±.02 
50 ill @ 5il9/m l 
0.00 2.377± 0 86 ± 1 10.60±.57 0.119±.008 0.38 ±.03 
0.00 2.374±.004 87 ± 1 10.60±.45 0.119±.009 0.39 ±.03 
0.0007 2.374±.001 87 ± 1 10.57±.57 0.120±.007 0.40 ±.01 
0.0007 2.378±.001 84 ± 1 10.26±.56 0.119±.009 0.40 ±.01 
0.007 2.376±.001 90 ± 1 11.23±.53 0.115±.005 0.39 ±.01 
0.007 2.382 ±.011 90 ± 1 11.10±.42 0.116±.005 0.39 ±.02 
0.07 2.415±.004 93 ± 1 11.36±.54 0.114±.006 0.34 ±.01 
0.07 2.408±.007 93 ± 1 11.41±.74 0.114±.007 0.34 ±.01 
0.12 2.451±.001 93 ± 1 11.60±.86 0.113±.009 0.33 ±.01 
0.12 2.448±.033 94 ±1 11.61±.87 0.113±.008 0.33 ±.02 
100 ill @ 5il9/ml 
0.00 2.483 ±.039 86 ± 2 9.89± .45 0.127±.007 0.44 ±.07 
0.00 2.484 ±.041 87 ± 2 9.80± .55 0.128±.008 0.44 ±.06 
0.0007 2.489 ±.045 86 ± 1 9.89± .65 0.125±.007 0.44 ±.06 
0.0007 2.483 ±.033 83 ± 1 9.50± .47 0.125±.005 0.43 ±.05 
0.007 2.473 ±.021 91 ± 1 10.49 ± .41 0.124±.005 0.38 ±.02 
0.007 2.466 ±.010 89 ± 2 10.42 ± .41 0.123±.007 0.38 ±.04 
0.07 2.506 ±.023 95 ± 1 11.10± .91 0.120±.011 0.32 ±.02 
0.07 2.497 ±.020 95 ± 1 11.06 ± .88 0.120±.011 0.32 ±.02 
0.12 2.493 ±.006 95 ± 0 11.71 ±1.08 0.113±.012 0.31 ±.01 
0.12 2.492 ± 0 95 ± 1 11.72 ±1.07 0.113±.012 0.31 ±.01 
200ill @ 5il9/ml 
0.00 2.589±.014 86 ±1 9.08 ±.29 0.137±.005 0.37 ±.06 
0.00 2.588±.009 86 ±1 9.19 ±.26 0.135±.004 0.38 ±.04 
0.0007 2.606±.020 85 ±1 9.23 ±.35 0.134±.004 0.37 ±.04 
0.0007 2.589±.006 83 ±1 8.93 ±.29 0.134±.004 0.37 ±.04 
0.007 2.587±.002 91 ±1 9.31 ±.31 0.142±.008 0.32 ±.02 
0.007 2.586±.002 89 ±1 9.20 ±.40 0.140±.007 0.32 ±.02 
0.07 2.587±.002 95 ±1 10.11 ±.09 0.133±.002 0.28 ±.01 
0.07 2.581±.001 94 ±1 10.03 ±.02 0.134±.001 0.32 ±.06 
0.1 2 2.554±.002 96 ±1 9.89 ±.06 0.139±.001 0.26 ±.01 
0.12 2.554±.002 95 ±1 9.88 ±.22 0.138±.003 0.25 ±.01 
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TABLEXIXb 
Chromatographic Results for MBC when [Buffer] in the Sample Solvent increases from 
o to 0.12M and Injected Mass of Analytes Increases with Increasing Injection Volume. 
[BUFFER] RETENTION AREA PEAK HEIGHT PEAK WIDTH SYMMETRY 
M TIME (min) (mAUs) (mAU) (min) 
10lll @ Sllg/ml 
0.00 3.312±.018 109±1 7.82±.16 0.203±.004 0.38±.02 
0.00 3.318±.018 109±2 7.8S±.14 0.198±.001 0.39±.02 
0.0007 3.314± 0 11H1 8.0H.01 0.198±.003 0.39±.02 
0.0007 3.31S±.001 113±2 8.02±.09 0.200±.001 0.40±.01 
0.007 3.322±.004 112±2 7.87±.07 0.20S±.008 0.39±.01 
0.007 3.323±.002 110±1 7.83±.08 0.20S±.002 0.39±.01 
0.07 3.323±.001 11H1 7.89±.04 0.204±.006 0.39±.01 
0.07 3.318±.001 112±3 7.84±.08 0.210±.002 0.38±.01 
0.12 3.320±.002 112±2 7.85±.05 0.206±.004 0.39±.01 
0.12 3.322±.003 111±3 7.88±.17 0.20S±.006 0.38±.02 
SO III @ 51l9/mL 
0.00 3.370±.002 120±1 8.95±.02 0.196±.001 0.35±.01 
0.00 3.368±.002 119±1 .8.85±.01 0.197±.002 0.35±.01 
0.0007 3.368±.00S 121±3 8.86±.01 0.199±.004 0.34±.01 
0.0007 3.370±.001 120±2 8.88±.03 0.199±.001 0.3S±.01 
0.007 3.367±.009 119±1 8.84±.01 0.197± 0 0.3S±.01 
0.007 3.376± 0 120±3 8.83±.03 0.198±.002 0.34±.01 
0.07 3.36S±.001 119±0 8.89±.OS 0.197±.001 0.35±.01 
0.07 3.366±.003 118±1 8.87±.OS 0.196±.001 0.35±.01 
0.12 3.373±.010 120±2 8.93±.01 0.195±.003 0.35±.01 
0.12 3.384±.029 12H1 8.95±.04 0.197± 0 0.3S±.01 
100lll @ 51lg/mL 
0.00 3.453±.031 122±2 9.12±.14 0.196±.006 0.36±.01 
0.00 3.452±.036 122±1 9.05±.12 0.199±.004 0.3S±.01 
0.0007 3.457±.038 119±1 9.00±.07 0.195±.001 0.36±.01 
0.0007 3.451±.024 120±1 9.02±.10 0.195±.003 0.35±.01 
0.007 3.438±.014 122±1 9.06±.11 0.193±.007 0.36±.03 
0.007 3.428±.006 12H3 9.04±.07 0.197±.004 0.35±.01 
0.07 3.435±.018 122±0 9.20±.13 0.195±.003 0.3S±.01 
0.07 3.424±.012 123±0 9.17±.10 0.195±.003 0.34±.01 
0.12 3.409±.001 123±1 9.32±.13 0.192±.005 0.35±.01 
0.12 3.406±.007 124±1 9.41±.16 0.192±.002 0.35±.01 
200lll @ 51lg/mL 
0.00 3.534±.003 122±3 9.18±.18 0.196±.004 0.3S±.01 
0.00 3.531±.008 121±3 9.09±.14 0.197±.001 0.35±.01 
0.0007 3.543±.020 12H2 9.06±.13 0.198±.001 0.34±.01 
0.0007 3.533±.001 12H2 9.07±.08 0.197±.004 0.34±.01 
0.007 3.530± 0 12H3 8.89±.16 0.203±.007 0.35±.01 
0.007 3.529± 0 12H3 8.89±.16 O.208±.OO7 O.3S±.01 
0.07 3.516±.OO1 124±1 9.06±.18 0.203±.O04 0.34±.O1 
0.07 3.512±.OO2 123±1 9.00±.14 0.204±.004 0.35±.O1 
0.12 3.497±.004 124±1 9.16±.13 0.204±.OO7 0.35±.02 
0.12 3.494±.006 124±1 9.17±.04 0.200±.OO1 0.36±.01 
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Fjaure 55: Chromatograms of STB (1) and MBC (2) tor increasing Mass Study Showing the Effects of 
Increasing Buffer Concentration in the Sample Solvent: 1) a.OM; 2) O.0007M; 3) O.007M; 
4) O.07M; 5) O.12M. 
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Eigure 56; Plot of Retention Time vs. 10g[Buffer Concentration] for STB 
at Increasing Analyte Mass for 10,50, 100 and 200 J.lL 
Injections. 
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Figure 57: Plot of Retention Time vs. log[Buffer Concentration] for MBC 
at Increasing Analyte Mass for 10, 50, 100, and 200 J.lL 
Injections. 
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Figure 58: Plot of Peak Height vs. 10g[Buffer Concentration] for STB 
at Increasing Analyte Mass for 10, 50. 100 and 200 ~l 
Injections. 
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Figyr~ 59; Plot of Peak Height vs. 10g[Buffer Concentration] for MBC 
at Increasing Analyte Mass for 10,50,100, and 200 III 
Injections. 
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Figure 6Q: Plot of Peak Width vs. 10g[Buffer Concentration] for STB 
at Increasing Analyte Mass for 10,50,100 and 200 j.LL 
Injections. 
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the constant mass study. 
Peak Widths A small decrease in the STB peak widths was 
observed for 10, 50, and 100 pL injections at higher buffer 
concentrations. At 200 uL injection, no trend could be 
established. The results are shown in Figure 60. There was no 
pronounced influence on th~ MBC peak width, as can be seen in 
Figure 61. 
Peak Area As the buffer concentration increased from ° to 
0.12 M, an increase in the peak area of STB was observed. The 
possible reasons for this will be discussed in section IV. The 
peak area of MBC was not affected by the change in the buffer 
strength. 
Peak Symmetry For ST~, small increases in the peak symmetry 
were observed for 50, 100, and 200 uL injections while MBC 
symmetry was not influenced by the buffer concentration. 
E. Additional Experiments 
1.Sample Solution pH 
The true pH values in a buffered water-organic solvent 
medium could not be measured_accurately with the conventional 
pH meter and the aqueous buffer standards due to the 
difference in the liquid junction potential and the activity 
coefficients in the aqueous and the mixed solvents (75). For 
this reason pH values of the buffer solutions which were added 
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Table XX 
pH of Buffer Added and the Apparent pH* of the Sample Solutions 
at Various Compositions. 
%CH:3CN pH of Buffer Apparent pH* 
in Sample Sol. Added of Sample Sol. 
5.0 7:00±.02 7.36±.O1 
25.0 7.00±.02 7.74±.02 
35.0 7.00±.02 7.92±.04 
50.0 7.00±.02 8.20±.04 
%CH~H pH of Buffer Apparent pH" 
v 
of Sample Sol. in Sample Sol. Added 
5.0 7.00±.02 7.38±.O1 
25.0 7.00±.02 7.83±.04 
35.0 7.00±.02 8.12±.O1 
50.0 7.00±.02 8.61±.03 
(Buffer] pH of Buffer Apparent pH"' 
M Added of Sample Sol. 
0.0000 7.00±.02 6.11±.05 
0.0007 7.00±.02 7.36±.20 
0.0070 7.00±.02 7.35±.O1 
0.0700 7.00±.02 7.35±.08 
0.1200 7.00±.02 7.13±.O1 
Buffer pH pH of Buffer Apparent pH" 
Added of Sample Sol. 
5.0 5.00±.02 5.59±.O1 
6.0 6.00±.02 6.35±.03 
7.0 7.00±.02 7.38±.O1 
8.0 8.00±.02 8.22±.07 
Mobile Phase 7.00±.02 7.97±.10 
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to the sample solution, and the apparent pH* of the s~lution 
are reported in Table XX. A significant influence of the 
organic solvent concentration in the sample solvent on the 
apparent pH* was observed. As the concentration of the 
acetonitrile increased from 5 to 501., the apparent pH* 
increased from 7.36 to 8.20. The increase in the methanol 
concentration from 5 to 501. produced an increase in the 
apparent pH* from 7.38 to 8.61. The apparent pH* of the mobile 
phase, which contained 351. acetonitrile, was 7.97. This 
pronounced influence of the organic solvents on the apparent 
pH* of the phosphate buffered sample solutions can be 
attributed_to the influence of the organic solvents on the pKa 
values of the buffered salts. The similar influence on the 
phosphate buffers was reported by Leitold and Vigh (57). 
The increase in the buffer concentration and therefore 
in the ionic strength of the sample solution, from 0.0007 to 
0.07, gave constant apparent pH* readings of 7.3. For the 
solution with buffer concentration of 0.12 M, apparent pH* was 
7.13. 
When the pH of the added buffer was varied, the observed 
pH* of the sample solution was influenced to different extent 
as can be seen in Table XX. This difference in the apparent 
pH* can be attributed to the variation in the buffering 
capacity of the phosphate buffer. 
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2.Ultra Violet Spectra of Sample Solutions 
The UV absorbance profiles of the two compounds at 
various sample solvent compositions, presented some 
interesting observations as shown in Figure 62a. The 
absorbance profiles for MBC appeared unaffected by the changes 
in the organic solvent concentrations, in the ionic strength 
or in the pH of the sample solutions. The possible reasons 
will be discussed in the section IVA. For STB the absorbance 
profiles were affected quite markedly by the changes in the 
sample solvent composition. The most pronounced changes 
occured in the pH study as shown in Figure 62a. The changes in 
the absorbance profiles for the remaining three studies also 
seem to be dependent on the pH of the solution. For the buffer 
concentration sudy the absorbance profile for the unbuffered 
soultion at pH of 6.11 was quite different from the buffered 
solutions. It was however quite similar to the absorbance 
profile for the solution at pH 6.35 in the pH study. The 
profiles for the solutions at varying ionic strength but the 
same pH were very similar. For 0.12 M buffer concentration, 
where pH was slightly lower, absorbance maximum was shifted 
back to slightly higher wavelength. The changes in the 
absorbance profiles for the solutions at increasing organic 
solvent concentrations seem to be related to the increase in 
the apparent pH*. The increase in the organic solvent resulted 
in the broader absorption bands with the absoption maxima 
% CH3(A\J 
in Sample Sol. 
5.0 
25.0 
35.0 
50.0 
%CH30H 
in Sample Sol. 
5.0 
25.0 
35.0 
50.0 
[Suffer] 
M 
0.0000 
0.0007 
0.0070 
0.0700 
0.1200 
Suffer pH 
5.0 
6.0 
7.0 
8.0 
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Table XXI 
Influence of Sample Solvent Composition on the UV Absorbance Profile 
of STS and MSC 
Amax Abs. at Amax Abs. at '-280nm 
MBC STS MSC STB MSC STS 
279.3 279.1 0.377 0.265 0.382 0.269 
279.8 276.4 0.370 0.273 0.375 0.273 
279.5 276.2 0.365 0.277 0.371 0.274 
280.0 274.9 0.359 0.280 0.364 0.273 
A m a x Abs.at ~ Abs. at A 280nm 
MBC STS MBC STB MSC STS 
279.3 279.5 0.379 0.264 0.385 0.269 
279.3 276.2 0.380 0.275 0.382 0.275 
279.3 275.5 0.376 0.282 0.381 0.278 
279.3 275.5 0.374 0.294 0.380 0.284 
Amax Abs. at '''max Abs.at Amm, 
MBC STS MBC STB MSC STS 
279.6 282.5 0.367 0.269 0.367 0.263 
279.6 278.5 0.367 0.269 0.367 0.261 
279.6 278.1 0.366 0.269 0.368 0.263 
279.6 278.5 0.368 0.264 0.370 0.265 
279.4 278.5 0.371 0.265 0.374 0.268 
Amax Abs. at Arrax Abs. at A280nm 
MSC STB MBC STB MSC STB 
280.7 282.9 0.389 0.274 0.385 0.272 
280.7 282.9 0.383 0.271 0.383 0.272 
279.5 278.9 0.383 0.266 0.380 0.270 
280.3 273.1 0.380 0.283 0.383 0.270 
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Figure 628: Effects of Sample Solvent Composition on the UV Absorbance Pf:ofiies of STB 
and MBC from 340 to 240 nm before Chromatographic Analysis: 1) Acetonitrile 
Increase; 5 to 50010; 2) Methanol Increase; 5 to 50%: 3) pH Increase; 5.0 to 8.0: 4) 
Buffer Concentration Increase; 0.00 to O.12M. 
STB 
1 
240 340 240 340 
2 
240 340 240 340 
I 3 
240 340 240 340 
I 
240 340 240 
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Figure 62b: UV Absorbance Profiles of STB and MBC from 340 to 240 nm as they were Eluted 
from the HPLC Column:1) Acetonitrile Increase; 5 to 50%; 2) Methanol Increase; 5 
to 50%; 3) pH Increase; 5.0 to 8.0; 4) Buffer Concentration Increase; 0.00 to 
O.12M. 
STB MBC 
1 
2 
1 
3 
4 
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being shifted to lower wavelengths. This was similar to the 
trend observed at increasing pH in the pH study. 
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IV. Discussion 
A.Compounds Studied 
As mentioned in the introduction, the two compounds 
studied were degradation products of fungicide benomyl and 
were shown to possess fungitoxic properties themselves (79). 
They have in common a large benzimidazole moiety and an amide 
functionality and would be expected to have similar 
chromatographic properties. This, however, is not necessarily 
the case. During our study it became apparent that the two 
compounds can be influenced in some cases in very different 
ways by the sample solvent. The difference between the two 
compounds was also indicated earlier by Singh and Chiba (79). 
It was not completely understood why the two compounds exhibit 
different chromatographic behaviour. It was of interest to 
explain this different behavior, especially since there are 
some questionable explanations in the literature (70,82) for 
similar type of behavior. To achieve this we used several 
analytical methods to probe the behavior of the two compounds 
in the solution and to learn more about their chemical 
properties. 
The molecular structure of MBC consists of the 
benzimidazole, amide and methoxy functionalities as shown in 
Figure 5 (II). It is smaller in size than STB and is capable 
of forming intramolecular hydrogen bonds (Figure 63). The 
absence of any solvent influence on the UV absorbance profiles 
132 
FI G U R E 63: Hydrogen Bonding and Solute-Solvent Interactions 
for "MBC and STB 
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'\ 
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2 
3 
133 
of MBC (Figure 62a) suggests the following two possibilities. 
Firstly, the absence of organic solvent influence on the 
absorbance profile strongly suggests that the amide carbonyl 
oxygen was involved in the intramolecular hydrogen bonding as 
shown in Figure 63 and therefore unavailabe for solvent 
interaction. The carbonyl ox~gen that is not involved in the 
hydrogen bonding was shown to be strongly influenced by the 
solvent polarity (83). Secondly, the absence of any pH 
influence suggests that amide and amine protons were not prone 
to the dissociation in the pH range tested. The involvement of 
a carbonyl oxygen in the intramolecular hydrogen bonding would 
minimize electron withdrawing presence from the amide 
nitrogen,making it more basic with higher dissociation 
constant and therefore much less influenced by the pH 
variations than STB. The intramolecular hydrogen bond 
formation would also decrease the tendency of the amide 
hydrogen to interact with the solvent molecules (84). The 
intramolecular hydrogen bond formation is also consistent with 
the absence of dimers in the FAB mass spectral analysis since 
carbonyl oxygen would not be available for dimer formation. 
STB is a larger molecule consisting of a more rigid 
three ring structure and a freely moving butyl group which 
could have a major influence in the hydrophobic retention 
mechanism (Figure 5 III). It has no capability of forming 
intramolecular hydrogen bonds but it is capable of forming 
intermolecular bonds at three different positions as shown in 
Figure 63. 
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TableXXlla 
Retention Factor k' 
for STS at Increasing pH 
pH k' 
4.42 0.83 
5.95 0.72 
6.50 0.54 
6.74 0.51 
7.40 0.48 
7.90 0.46 
9.10 0.45 
Table XXllb 
UV Absorbance Values at 291 nm 
for STS at Increasing pH 
pH A(a.u.) 
5.59 0.366 
6.35 0.345 
7.38 0.282 
8.22 0.258 
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Figure 64: Plot of UV Absorbance vs. pH of the Sample Solution for STB at 291 nm. 
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As demonstrated in Figure 62a, a significant influence of 
the sample solvent on the STB absorbance profile was observed. 
There are three possible explanations for these interactions. 
As reported in the results section, the most pronounced change 
occurred in the pH study and especially between pH 6 and pH 7. 
The changes in the other three factors could also be pH 
dependent since the pH* of the solutions increased as the 
concentration of the organic solvent in the solution 
increased. The pH influence suggests the possible occurrence 
of dissociation in this pH range. Jaffe and Orchin (83) 
reported that the dissociation constant Ka can be obtained by 
determining the absorption spectra of a series of solutions at 
constant concentrations but at varying apparent pH*, and by 
plotting absorbance vs pH* at constant wavelength. The middle 
of the inflection point can be estimated as the apparent pKa* 
of the analyte in the mixed solvent. The apparent pKa* for STB 
at 291 nm was estimated at 6.5 from the plot in Figure 64. The 
pKa for STB was also determined from the plot of retention 
factor k' vs pH of the sample solution (Figure 65) and was 
found to be in the 6.5 pH range. A second explanation for the 
change in the absorbance is the formation of the complex with 
the buffer species. At increasing pH, the amide proton becomes 
more acidic and therefore more prone to the interaction with 
the negatively charged buffer species, which would result in 
the band broadening. The third possibility could be the 
involvement of carbonyl oxygens in the hydrogen bond formation 
with protonated solvents such as methanol (Figure 63). It has 
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been shown that the absorption curves of dike tones are 
influenced by the solvent and that the maxima are shifted to 
the shorter wavelength as the polarity of the solvent 
decreases (85). The formation of the intermolecular hydrogen 
bonding is also supported by the presence of STB dimers in the 
FAB mass spectral analysis .in 3-nitrobenzyl alcohol. The 
significantly higher base peak for STB than MBC in the FAB 
analyses suggests much higher tendency of STB to ionize. 
The UV absorbance profiles of both compounds, taken as 
they were eluted from the column after chromatographic 
separations, were the same in all the cases regardless of the 
sample solvent compositions and were identical to the 
absorbance profiles of the two compounds which were 
specifically prepared in the mobile phase solvents for the 
comparison purpose (Figures 62a and 62b). This result suggests 
that the analytes eluted from the column were determined by 
the detector without any influence from the sample solvent 
composition. 
B. Effect of Sample Composition 
The effect of the sample solvent composition on the 
chromatographic peak profile in RP-HPLC has been studied by 
several workers (63-77, 82), but most of these studies have 
been published in the last few years. This indicates that this 
topic is relatively new and gaining in importance. 
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At present the recommended procedure for RP-HPLC 
analyses is to inject the smallest volume possible (1-10 pL), 
and to dissolve the sample in the mobile phase in order to 
minimize baseline disturbances. In many instances adherence to 
this rule is not practical or is just not followed. Carbas et 
ale (SO) analysed MBC and related fungicides using 
acetonitrile as the injection solvent and 
water:acetonitrile:phosphate buffer pH 7 (45:45:10) v/v % as 
the mobile phase solvent. They obtained very poor peak 
resolution and chromatographic efficiency. This was primarily 
due to the use of a sample solvent which is much stronger in 
eluting power than the mobile phase. In many cases mixtures of 
compounds to be analysed have a wide range of solubilities. 
For this reason two or more solvents are required to 
completely dissolve all the components. Because of this reason 
Chiba and Singh (65) used methanol, acetonitrile, and 
phosphate buffer in the sample solvent composition. They 
observed that the peak response and the resolution of STB and 
MBC were influenced by the pH, buffer concentration and the 
organic solvent concentrations. 
The main objective of this research was to determine to 
what extent the peak profile is affected by changing the 
sample solvent compositions, to try to explain possible 
reasons for this influence, and to suggest possible ways to 
optimize sample compositions. For this purpose the effect of 
two common organic solvents (methanol and acetonitrile), and 
the effects of the solution pH and the buffer concentration 
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were examined. 
1. Effects of Acetonitrile in the Sample Solution 
Acetonitrile is one of the most important organic 
solvents in RP-HPLC. It is a relatively polar, nonprotic 
solvent which eluting strength in RP-HPLC (3.1) is slightly 
higher than that of methanol (3.0) and much higher than that 
of water (0) (48). It was observed that the acetonitrile 
concentration in the sample solvent showed a strong influence 
on the retention time, peak height and peak width for the both 
compounds studied (Figures 6-19). An increase in the 
acetonitrile concentration in the sample solution from 5 to 
50% resulted in a significant decrease in the retention times 
and peak heights and an increase in the peak widths (Figure 
7-12). The effects became more pronounced as the eluting 
strength of the sample solvent became higher than that of the 
mobile phase. The reason for the peak height reduction and 
peak broadening with an increase in the acetonitrile 
concentration can be attributed to the increase in the eluting 
strength of the sample solution. N~ and Ng (69) suggested that 
the effects of the sample solvent are also due to the change 
in the retention capacity of the column which results from the 
adsorption of the injection solvent onto the column. The peak 
broadening, which occured with the increase in the 
acetonitrile concentration, was in contrast to the mobile 
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phase effect where increase in the eluting strength usually 
results in the sharper peaks. The study demonstrated that the 
variations in the acetonitrile concentrations of only 10 or 
20% could introduce significant errors into the quantitative 
results if peak heights are used in calculations. It also 
showed that the use of mobi~e phase composition in the sample 
preparation does not necessarily lead to the most efficient 
separation. For this reason solvents used in sample 
preparation should be aqueous or contain a minimum percentage 
of organic solvent necessary for complete dissolution of 
analytes. 
At high injection volumes (100, 200 pL) and high 
acetonitrile concentrations (50%), split peaks were observed 
for STB but not for the longer retained MBC. Split peaks most 
often result when more than one retention mechanism is present 
or when a solute is preferentially soluble in one of the 
sample solvents (73-76). If peak splitting occurs, erroneous 
interpretation of the results could be obtained from more than 
one peaks regardless whether the peak height or area is used 
for measurements, if one is not aware of the peak splitting 
possibility and assumes that the extra peaks are due to sample 
impurities. Another important observation that came out of 
this study was the fact that the peak heights of the two 
analytes were affected to a different extent by the variation 
in the sample solvent composition (Figures IX and X). This 
observation has important implications for quantitative 
analyses by peak heights even if an internal standard is used, 
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since peak height responses may not be the same for the 
analyte and the standard. 
Results in this study are consistent with the 
observations of several other groups that studied different 
types of compounds. Tsimidou and Macrae (68) found in their 
study of triglycerides, tha~ sample solvents higher in eluting 
strength than the mobile phase may cause band broadening and 
in some cases peak-splitting. Since they used organic solvents 
for the sample dissolution which were different from the 
mobile phase, they attributed peak splitting to the 
incompatibility of the two solvents. In this study, peak 
splitting occured when the sample solvent was the same as the 
mobile phase (acetonitrile), and also when it was different 
(methanol). Williams et ale (67), in their study of sample 
solvent effect on Aspirin and related analgesics reported 
similar effects for acetonitrile. Ng and Ng (69) found that 
injection of decamethrin, a synthetic pyrethroid insecticide, 
in a solvent of stronger eluting power than mobile phase can 
produce two well resolved peaks. When the same compound was 
injected in the mobile phase, a single peak was observed. 
Perlman and Kirschbaum (70) and Kirschbaum and Perlman (86) 
observed that in a single component solvent such as water, 
methanol, acetonitrile or ethanol, significant reductions in 
the peak heights occured as the injection solvent became less 
polar. Since they observed this phenomenon only for compounds 
that are capable of forming intramolecular hydrogen bonding, 
they concluded that this is a phenomenon particular only to 
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these type of molecules. The results of this study disprove 
their theory since the reduction in peak heights occured for a 
compound capable of forming hydrogen bonding (MBC) and one 
that is not (STB). Berridge (82) also disputed Kirschbaum's 
conclusions. He reported reduction in the peak heights for 
captopril, which is capable.of intramolecular hydrogen bond 
formation, and for p-hydroxybenzoate which cannot form 
intramolecular hydrogen bonds. 
2. Effect of Methanol Concentration in the Sample Solution 
The methanol concentration effects for MBC were very 
similar to those of acetonitrile, but were quite different for 
STB. The retention times and peak heights of MBC decreased and 
peak widths increased with an increase in methanol 
concentration. The behaviour for MBC could be attributed 
primarily to the increase in the eluting strength of the 
sample solvent. The influence of methanol on the STB peak 
profile was quite different. Here retention times and peak 
heights increased and peak widths decreased with an increase 
in methanol concentrations. At higher analyte concentrations 
and higher injection volumes (100 and 200 pL) peak splitting 
was observed (Table Xllla). There are several interesting 
observations in the peak splitting pattern. As mentioned 
earlier, peak splitting usually indicates the presence of more 
than one factor that can effect retention mechanism, and this 
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seemed to be the case in the present study. At 100 ~L 
injections, split peaks were observed at 25% methanol in the 
injection solvent. The areas of the split peaks were equal. 
The retention time of one peak was the same as that of MBC in 
5% methanol solution and for the second peak was sharply 
increased. At 35 and 50 % methanol, no splitting was observed 
but a large increase in the peak width and significant change 
in the peak symmetry was observed. At 200 ~L, split peaks 
occured for 25, 35 and 50% methanol concentrations. As the 
methanol concentration increased marked changes in the areas 
of the split peaks were observed. At 25 and 35% methanol the 
peaks which eluted first had a larger area while at 50% 
methanol the area of the longer retained peak became much 
larger, and the retention of the smaller first peak became 
much shorter (Table XIIIa). 
There could be several reasons for methanol effects on 
STB that are quite different from the acetonitrile effects. 
The major reason could be the tendency of STB to form 
intermolecular hydrogen bonds with methanol through carbonyl 
oxygens and in that way alter to some extent the primary 
hydrophobic mechanism. In the presence of intermolecular 
hydrogen bonding, the conformation of the STB molecule may be 
changed in such a way to make the butyl branch more 
important in the retention mechanism. Since this is a nonpolar 
group it will be retained more strongly by the nonpolar C-18 
stationary phase, resulting in a somewhat longer retention 
time. The intermolecular bond formation also results in higher 
145 
density of the sample solution which may reduce the initial 
diffusion of the sample molecules and result in narrower 
peaks. A second reason could be the modification of the 
stationary phase surface by methanol molecules. It was 
reported in previous papers (37,87) that methanol will 
interact with free silanols on the surface of the reverse 
phase packing material and make the surface more hydrophobic. 
Since STB possesses a large nonpolar n-butyl group, it would 
be more strongly retained than the more polar MBC. Titova et 
ale (88) suggested that the acetonitrile molecules may be 
adsorbed more strongly onto the stationary hydrophobic surface 
than more polar methanol molecules. This modification of the 
stationary phase could also explain why a more pronounced 
decrease was observed in the retention time for acetonitrile 
study than for methanol study. As the injection volume and the 
methanol content increase, the modification of the stationary 
phase and the conformational influence could become more 
important which would explain the observed increase in the 
peak area of the longer retained split peak. The less 
pronounced decrease in the peak heights of MBC for methanol 
study than was seen in acetonitrile study may also be due to 
fewer interactions between the methoxy group on MBC and the 
surface silanols. Another reason could be that as the methanol 
content increases up to 40%, the viscosity of the sample 
solvent also increases as was demonstrated by Colin et al. 
(89). The viscosity increase reduces sample diffusion which 
can result in increased peak height and reduced peak width. 
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Since STB has smaller retention factor k', this increase in 
efficiency for STB becomes more pronounced than for the longer 
retained MBC. As methanol concentration increases over 40%, 
the viscosity of the sample solution begins to decrease which 
may once again encourage band spreading. Around the same time, 
the solvent strength becomes higher than that of mobile phase, 
this also contributes to band broadening. 
Williams et ale (67) also observed peak height increases 
for Aspirin and related analgesics, up to around 35% methanol 
in the sample solvent. Their findings, which were obtained 
using an ODS II column, eliminate any doubts that our results 
may be limited to a particular column. 
3. Effect of pH in the Sample Solution 
Increase in the pH of sample solvents from pH 4 to pH 9 
resulted in a substantial increase in the peak heights and a 
decrease in the retention time and peak widths for STB 
(Figures 34-36 & Tables XIV-XVI). The retention time decrease 
became much more pronounced at higher buffer concentrations in 
the sample solvent (Table XIV). For MBC study, variations in 
the sample solvent pH up to pH 9 had no observable effect on 
the peak retention or peak profile. Only at pH 9 and at higher 
buffer concentration of O.06M was a small decrease in the peak 
width observed. This difference in the sample solvent effects 
on the two compounds can again be explained by the difference 
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in the chemical properties of the two molecules. As mentioned 
earlier, MBC is more stable at higher pH and unlike STB, has 
no tendency to ionize in the pH range that was studied. Its 
capability to form an intramolecular hydrogen bond makes it 
also less prone to interactions with the sample solvent. Both 
of these factors could be responsible for the absence of 
sample solvent influence. STB on the other hand is more prone 
to ionization and intermolecular bond formation as pH 
increases (Figures 64-67). The ionized form of STB becomes 
less retained by the nonpolar stationary surface resulting in 
a dec~ease in the retention time. The weaker interaction with 
the stationary phase also results in less peak broadening and 
therefore in a corresponding peak height increase. 
It appears that the effects of the sample solvent pH and 
of the mobile phase pH on STB peak profiles were very similar. 
Carbas et al.(80) in his study of benomyl and its degradation 
products found that an increase in the pH of the mobile phase 
caused a reduction in the retention time and an increase in 
the sharpness of the STB peaks. Similar effects were observed 
for other ionizable substances. Foley and May (90), in their 
study of secondary chemical equilibria of chlorobenzoic acids 
in RP-HPLC, found that increase in the pH of the mobile phase 
will result in increased selectivity and peak heights of the 
analytes. 
The above results lead to the conclusion that by 
controlling sample solvent pH one can control the efficiency 
and the resolution of ionizable solutes. This is illustrated 
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very well in Figure 34, where the increase in the pH of the 
sample solution, from 4.42 to 7.90, leads from no resolution 
to very well resolved peaks. 
4. Effect of Buffer Concentration in the Sample Solution 
An increase in the buffer concentration resulted in an 
increase in the retention time and in the substantial peak 
height increase for STB (Table XIX). While retention time 
increase was observed in the both, constant and increasing 
mass studies, the peak height enhancement was observed only in 
the increasing mass study. The possible explanation for this 
is that increase in the ionic buffer species can reduce the 
electrostatic repulsion between eluate molecules and increase 
the surface tension of the solvent. The solutions with higher 
solute concentations would experience greater effect and would 
therefore exibit reduced band broadening. The concentration 
dependent influence on the peak height of STB may also be due 
to the interaction of the STB molecules with the buffer 
species in the sample solution. As buffer concentrations 
increased, the interaction of phosphate anion with the amide 
proton of STB becomes greater. With the formation of 
STB-buffer complex, one would expect that the molecule would 
interact less strongly with the nonpolar stationary phase. As 
a result the retention time would decrease. The opposite was 
in fact true, as can be seen from the increase in retention 
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times observed when the buffer concentration increased. The 
most logical explanation for this is that the molecular 
conformation has been altered in such a way that butyl branch 
becomes a dominant factor in the retention mechanism. The 
nonpolar group has a stronger hydrophobic interaction with the 
stationary phase which resu~ts in a retention time increase. 
Another explanation could be that buffer species become 
adsorbed by the stationary phase and in this way alter 
retention mechanisms. This could also explain the behaviour of 
MBC. In this case a reduction in the retention time was 
observed as buffer concentrations increased, but peak height 
and peak width were not influenced. As the buffer 
concentration increased, more polar silanol groups became 
blocked by the adsorbed buffer species limiting silanol 
interaction with the polar MBC groups. Berthod et ala (91) 
reported behaviour similar to the results in this study for 
mobile phase effects in the study on surfactant 
concentrations. They found that the retention of neutral 
substances (caffeine, toluene) decreased when the amount of 
adsorbed surfactant was increased. When an anionic surfactant 
was adsorbed, the retention of negatively charged solutes, 
such as benzoate, fell sharply, and the retention of cationic 
substances, such as benzyltrimethyl ammonium bromide, 
increased. The cationic surfactant had opposite effect. 
By maintaining the same buffer concentration, but 
changing the acetonitrile concentration from 5 to 35% 
different results were obtained for STB. At higer acetonitrile 
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concentrations retention times seemed almost constant while at 
lower acetonitrile concentrations an increase in the retenion 
was observed. The peak heights increased slightly more at a 
lower acetonitrile concentraion (26.5% for 10 pL injection at 
5%), than at a higher concentration (19.7% for 10 pL injection 
at 35%) (Tables XVII, XVIII~ XIX). 
Another interesting observation was that as the buffer 
concentration in the sample solvent increased, the peak area 
of STB also increased. This was the only occasion that the 
peak area showed some response to the change in factors except 
in the case of peak splitting. The reason for this could be 
the presence of STB-buffer complex which may slightly enhance 
the absorbance readings at the wavelength used for this study. 
This conclusion was supported by a special series of 
experiments conducted to measure the UV spectra of STB sample 
solutions which were prepared with different solvent 
compositions. The results of the study indicated that 
absorbance increased as the buffer concentrations increased 
(Table XXI). The importance of keeping ionic strength of the 
mobile phase constant has been shown by others (30,90).The 
above results emphasize the importance of keeping a constant 
ionic strength in the sample solutions also. 
c. Injection Volume 
The reason for studying injection volumes was the fact 
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that column suppliers with microparticulate packings of 5 ~m 
or less recommend using injection volumes of less than 10 pL 
for optimum chromatographic results (92). In practice, 
however, this advice is very often not observed and volumes of 
50 and 100 ~L are still routinely used. Several reasons exist 
for using larger injection ~olumes. For very dilute samples, 
such as in trace analysis, there is a limit in detector 
sensitivity for many existing older model systems and it is 
necessary to preconcentrate samples before chromatographic 
run. The possibility of using larger injection volumes would 
reduce the need for preconcentration. Limitations fer UV 
detectors are also due to the detector cell size. For the 
Perkin-Elmer instrument used in the first part of this study, 
the detector cell size was 8 uL and if sample volume is much 
smaller, band broadening due to the large cell size will 
eliminate any chromatographic efficiency obtained using 
smaller injection volumes. In some cases of trace and residue 
analyses, samples must be completely dissolved and total 
quantity injected. Dissolution is very dificult in volumes 
smaller than 50 to 100 pL. It was also of interest to see how 
sample compositions influence peak profiles at different 
injection volumes. This aspect was investigated in this study 
by preparing two series of s~mples. The influence of injection 
volume at constant injection mass was studied by injecting 10, 
50, 100, and 200 ~L of successively more dilute sample 
solutions of 5, 1, 0.5, 0.25 ~g/mL, respectively. In this case 
the same amount of analyte was introduced onto the column at 
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all four injection volumes. The influence of injection volume 
at increasing mass was studied by injecting 10, 50, 100, and 
200 pL of sample solution at a constant concentration of 5 
pg/mL. In this case an increasing amount of analyte was being 
injected onto the column with increasing injection volume. 
The profile of the injected band is characterized by the 
injection volume (30). It was shown (30) that the band 
variance (;) obeys following relationship: 
eq. [ 8 ] 
where V is the sample volume and Ais a numerical factor which 
depends on the mode of injection, with the usual value of 2. 
It was also shown that the maximum sample volume V is 
m 
proportional to the maximum detector cell volume Vdm and to 
the (t )1/2. The effects of the injection volume on the 
r 
chromatographic efficiency (N), where N 
reported in (93). This group found that at constant mass an 
increase in the injection volume from 10 to 500 ~L resulted in 
a substential decrease in the chromatographic efficiency. In 
our study we found that the composition of the sample solvent 
had a greater influence on the chromatographic efficiency than 
did injection volume as can be observed from Figures 66 and 
67. It could also be seen from these Figures that the 
efficiency does not necessarily decrease with the injection 
volume increase from 10 to 200 pL. In Figure 66, we can 
observe that at 5% acetonitrile in the sample solvent (at 
increasing mass study) the efficiency of both analytes 
increased with the increase in the injection volume. At 50% 
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Table XXIII* 
Chromatographic Efficiency(N)** at Increasing Injection Volume 
for STB and MBC at 5 and 50%(v/v) Acetonitrile in the Sample Solvent 
Injection 
Volume 
j..tL 5%CH3Q\J 
10 2250.39 
SO 2724.14 
100 3112.04 
200 3116.63 
*for Increasing Mass Study 
**N=5 .S2[tr/w( h/2) J2 
STB 
EFFICIENCY (N) 
MBC 
50%CH3CN 5% CH3Q\J 50% CH3CN 
1178.7S 2398.11 1766.05 
433.23 2148.07 927.03 
334.04 2397.45 526.08 
320.32 2524.68 202.17 
Table XXIV* 
Chromatographic Efficiency(N)** at Increasing Injection Volume 
for STB and MBC at Sand SO%(vlv) Methanol in the Sample Solvent 
Injection 
Volume 
j..tL 
EFFICIENCY (N) 
STB 
5% CH30H SO% CH30H 
10 
50 
100 
200 
1226.94 
1251.79 
1528.18 
1833.42 
*for Constant Mass Study 
** N=5 .52[tr/w( h/2)]2 
1150.30 
2042.56 
2254.55 
2001.26 
MBC 
5% CH3CH 50% CH30H 
1093.74 
1368.58 
1510.43 
1855.33 
1030.70 
1146.02 
1098.87 
881.60 
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figure 66: Plot of Efficiency (N) vs. Injection Volume for STB and MBC at 5 and 50% 
(v/v) Acetonitrile 
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Figure 67: Plot of Efficiency (N) vs. Injection Volume for STB and MBC at 5 and 50% 
(v/v) Methanol 
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acetonitrile in the sample, completely opposite results were 
obtained. Here decreases in the efficiency, of similar 
magnitudes, were observed for both compounds. Somewhat 
different results were obtained for the methanol study (Figure 
67). While at 5% methanol, similar efficiency increases were 
observed for both compounds, at 50% methanol, a pronounced 
increase was observed for STB while for MBG, efficiency 
gradually decreased at higher injection volumes. 
In discussing chromatographic efficiency, one has to 
remember that it is a function of retention time (t ) and the 
r 
peak width (w=4~). It should therefore be pointed out that as 
the injection volume increased the retention time of the 
analytes also increased. This increase contributes directly to 
the increase in the efficiency. Pronounced increases in the 
analyte retention times were observed at increasing injection 
volumes for lower percentage of the organic solvent than for 
the higher percentage (Tables IX-XIX). The larger increases in 
the efficiency at lower organic solvent content were also 
observed. At lower organic solvent contents the peak 
broadening, which is inversly proportional to the efficiency, 
was minimal or it actually decreased. At a higher organic 
solvent content, the differences in the retention times at 
various injection volumes became smaller and the peak 
broadening, which was qite substantial at the high organic 
solvent concentrations, became a dominant factor in 
controlling efficiency. 
The effect of injection volume was more clearly observed 
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with acetonitrile than with methanol. Both retention time and 
peak height decreased when organic solvent concentrations 
increased and this trend was more pronounced with an increase 
in the injection volume (Figures IX-XI), but the magnitude of 
the effect was different for STB and MBC. Almost identical 
results were observed for tbe studies at constant and 
increasing mass, when the injection volume was low (at 10 and 
50 ~L). When the sample solvent strength was much lower than 
that of the mobile phase, the peak width was not significantly 
affected by an increase in the injection volume. However, when 
the sample solvent strength was higher than that of the mobile 
phase, the peak height became substantially smaller, this is 
particularly tTue when larger volumes of injections were made 
(Figure IX-XI). Peak splitting was often observed at 100 and 
200 pL injections in the increasing mass study (Table Xa). The 
above observations are quite important since they suggest that 
by optimizing sample solvent composition a much larger 
injection volume can be used. 
The effects of an increasing methanol concentration in 
the sample solvent on the peak profile were not as straight 
forward as those fOT acetonitrile. FOT MBC, decreasing trends 
in the retention time and peak height weTe observed as the 
injection volume increased, but this trend was not as 
pronounced as that for the acetonitrile. For STB, increase in 
the injection volume gave mixed results for methanol increase. 
In the constant mass study, in which successively less 
concentrated samples were injected, increase in the efficiency 
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in relation to the methanol percentage increase was very 
insignificant with 10 ~L injections, but substantial increase 
was observed with 50 uL injections. This increase became less 
significant again with 100 and 200 pL injections. At a 200 pL 
injection volume and 50% methanol in the sample solvent a 
complete reversal in the peak height and efficiency was 
observed. The reason that the effects became smaller at higher 
injection volumes was most probably due to the presence of 
several effects on the retention mechanism of STB at the start 
of the analysis, which changed in the importance with the 
increasing injection volume. These effects were discussed in 
section IVB2. 
For the increasing mass study, where successively larger 
quantities of analytes were injected at increasing volumes, 
different effects were observed. The increases in the 
retention time were larger than those for the constant mass 
study, at higher injection volumes. The peak height increases 
and the peak width decreases were observed only for 10 and 50 
pL injections. At higher analyte concentrations, pronounced 
peak splitting and peak broadening were observed for 100 and 
200 pL inj'ections when methanol concentrations were higher 
than 5%. This suggests that at higher analyte concentrations, 
much smaller injection volumes can be tolerated for STB, if 
more than 5% of methanol is used in the injection solvent. 
In the pH study, the sample solvent effects on the peak 
profile of STB became more pronounced with an increase in the 
injection volume, while for MBe, injection volume increases 
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had no effect on the peak profile. 
In the buffer concentration study, analyte 
concentrations appeared to be an important factor. In the 
study where sucessively lower concentrations of samples were 
injected at higher volumes, injection volume effects were 
almost nonexistent. In the increasing mass study, increase in 
the injection volume had no pronounced effect on the peak 
heights and retention times for 10, 50 and 100 ~L injections. 
At 200 ~L injections, increases in peak heights and retention 
times for STB which were observed at lower injection volumes 
was replaced by peak height and retention time decreases 
(Tables XIXa and XIXb). 
v. Conclusion 
From the results of this study several important 
conclusions can be drawn about the effects of the sample 
solvent composition on the chromatographic peak profile. 
1. The amount and the type of organic solvents, the pH, and 
the buffer strength in the sample solution can have a 
pronounced effect on the peak heights and the retention times 
of the compounds analysed. 
2. Compounds that have low tendency to interact with the 
sample solvent, are not prone to ionization, or are capable of 
forming intramolecular hydrogen bonds show a predictable 
decrease in retention time and peak height and greater peak 
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broadening with an increase in the eluting strength of the 
sample solvent. 
3. Compounds that have a tendency to ionize or to strongly 
interact with the sample solvent molecules may be influenced 
in various ways by the changes in the sample solvent 
composition and these type of compounds are influenced to a 
much greater extent by the pH and buffer strength variations 
in the sample solvent. 
4. Effects of sample solvent on peak profiles can be different 
even for very similar group of compounds. For this reason, 
solvent compositions for both samples and standards should be 
kept constant; this is true even if the internal standard is 
used in the analysis. 
5. Use of the mobile phase for sample preparation does not 
always result in the most efficient chromatograms and whenever 
possible samples for reversed phase HPLC analyses should be 
prepared with the least amount of organic solvent. 
6. The effect of sample solvent compositions can be observed 
even with 10 pL injections. The effects, however, become more 
pronounced as injection volume increases. For this reason the 
smallest possible injection volume should be used if careful 
control of sample solvent composition is not possible. 
7. By optimizing sample solvent compositions, much larger 
injection volumes may be used without significant loss of 
chromatographic efficiency. 
8. The concentration of analytes becomes more important in the 
sample preparation if the analyte is capable of ionization or 
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has a strong interaction with the solvent. 
VI. Recommendations 
This study clearly demonstrated that the sample solvent 
composition can have pronounced effects on the chromatographic 
peak profiles. For this reason it is strongly recommended that 
all the samples and standards, regardless whether standards 
are external or internal, be prepared in a solution with the 
least percentage of organi6 solvent and analysed at a constant 
sample composition and a constant injection volume. 
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Appendix I 
Effects of Sample Solvent Composition on the 
Peak Profiles of STB and MBC obtained on PE-HPLC 
Page 
A2 
A3 
A4 
AS 
Effects of Acetonitrile Increase 
Effects of Methanol Increase 
Effects of pH 
Effects of Buffer Concentration 
A2 
Composition of Sample Solutions for Acetonitrile 
Concencentration Study on PE-HPLC 
'7. CH 3 CN '70 CH30H '70 0.07M Buffer [STB] [MBC] '7. H2O 
at pH llg/mL pg/mL 
5.00 5.00 10.00 5.00 5.00 80.00 
25.00 5.00 10.00 5.00 5.00 60.00 
35.00 5.00 10.00 5.00 5.00 50.00 
50.00 5.00 10.00 5.00 5.00 35.00 
Effect of Increasing CH 3CN Concentration in the 
Sample Solvent from PE-HPLC Study* 
5.00 
25.00 
35.00 
50.00 
Retention Time (min) 
STB MBC 
3.40+/- 0 
3.30+/-.02 
3.20+/-.02 
3.20+/-.04 
4.00+/- 0 
3.88+/-.02 
3.88+/-.04 
3.82+/-.02 
* at 50 pL injection volume 
Peak Height (cm) 
STB MBC 
9.30+/-.05 
8.74+/-.09 
8.56+/-.02 
6.39+/-.01 
12.51+/-.06 
11.94+/-.10 
11.56+/-.02 
9.77+/-.03 
A3 
Composition of Sample Solutions for Methanol 
Concencentration Study on PE-HPLC 
% CH30H 7. CH 3CN % 0.07M Buffer [STB] [MBC] 7. 
at pH 7 Jlg/mL Jlg/mL 
5.0 5.0 10.0 5.0 5.0 
25.0 5.0 10.0 5.0 5.0 
35.0 5.0 10.0 5.0 5.0 
50.0 5.0 10.0 5.0 5.0 
Effect of Increasing CH30H Concentration in the 
Sample Solvent on STB and MBC from PE-HPLC Study* 
H2O 
80.0 
60.0 
50.0 
35.0 
[CH 3OH] Retention Time (min) Peak Height (em) 
7. STB MBC STB MBC 
5 3.20+/- 0 4.00+/- 0 12.82+/-.13 17.72+/-.24 
25 3.20+/- 0 4.00+/- 0 12.88+/-.03 17.50+/-. 0 
35 3.18+/-.02 4.00+/- 0 13.27+/-.06 17.50+/-.25 
50 3.18+/-.02 4.00+/- 0 13.57+/-.42 17.48+/-.59 
* at 10 pL injection volume 
A4 
Composition of Sample Solutions for pH Study on PE-HPLC 
% CH 3 CN "1.. CH30H 0.07M Buffer [STB] [MBC] HiO )lg/mL )lg/mL 
5.00 5.00 10.00 at pH 5.00 5.00 5.00 80.00 
5.00 5.00 10.00 at pH 6.00 5.00 5.00 80.00 
5.00 5.00 10.00 at pH 7.00 5.00 5.00 80.00 
5.00 5.00 10.00 at pH 8.00 5.00 5.00 80.00 
5.00 5.00 10.00 at pH 9.00 5.00 5.00 80.00 
Effect of pH Increase in the Sample Solvent on 
the Peak Profiles of STB and MBC 
pH 
5.00 
6.00 
7.00 
8.00 
9.00 
Retention Time (min) 
STB MBC 
3.68+/-.02 
3.66+/-.06 
·3.56+/- 0 
3.46+/-.04 
3.48+/- 0 
4.14+/-.02 
4.14+/- 0 
4.14+/- 0 
4.14+/-.06 
4.18+/-.02 
* at 50 pL injection volume 
in PE-HPLC Study* 
Peak Height (cm) 
STB MBC 
8.07+/-.04 
8.33+/-.03 
9.30+/-.05 
9.78+/-.08 
8.71+/-.08 
12.98+/-.03 
12.87+/-.03 
12.51+/-.06 
12.82+/-.08 
12.67+/-.06 
A5 
Composition of Sample Solutions for Buffer Concentration 
Study on PE-HPLC 
CHiCN CHioH Buffer [STB] [MBC] H2O 
at pH 7.0 Jlg/mL Jlg/mL 70 
5.00 5.00 10.00 at 1. 200M 5.00 5.00 80.00 
5.00 5.00 10.00 at 0.700M 5.00 5.00 80.00 
5.00 5.00 10.00 at 0.070M 5.00 5.00 80.00 
5.00 5.00 10.00 at 0.007M 5.00 5.00 80.00 
Effect of Buffer Concentration in the Sample Solvent on the 
Peak Profiles of STB and MBC from PE-HPLC Study* 
[Buffer] Retention Time (min) Peak Height (em) 
M STB MBC STB MBC 
0.0007 3.34+/-.02 4.06+/-.04 12.83+/-.2 17.55+/-.4 
0.007 3.30+/- 0 4.08+/- 0 12.88+/-.07 17.72+/-.07 
0.07 -3.34+/-.04 4.10+/- 0 13.56+/-.5 17.62+/-.8 
0.12 3.28+/-.02 4.04+/- 0 14.00+/-.5 17.36+/-.5 
* at 10 JlL injection volume 
A6 
Appendix II 
Chromatograms of STB (1) and MBC (2) for Constant Mass Study Showing the Etiects of the 
Sample Solvent pH at Increasing Injection Volume, 
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Appendi x II I 
FAB Mass Spectra of MBC in 3-Nitrobenzyl Alcohol 
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